<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation - Cornelisse, S - 2020 | Cochrane Library</title> <meta content="Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation - Cornelisse, S - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005291.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation - Cornelisse, S - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005291.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005291.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation" name="citation_title"/> <meta content="Simone Cornelisse" name="citation_author"/> <meta content="Radboud University Nijmegen Medical Centre" name="citation_author_institution"/> <meta content="Miriam Zagers" name="citation_author"/> <meta content="Amsterdam UMC, University of Amsterdam" name="citation_author_institution"/> <meta content="Elena Kostova" name="citation_author"/> <meta content="Amsterdam UMC, University of Amsterdam" name="citation_author_institution"/> <meta content="Kathrin Fleischer" name="citation_author"/> <meta content="Madelon van Wely" name="citation_author"/> <meta content="Amsterdam UMC, University of Amsterdam" name="citation_author_institution"/> <meta content="Sebastiaan Mastenbroek" name="citation_author"/> <meta content="Amsterdam UMC, University of Amsterdam" name="citation_author_institution"/> <meta content="s.mastenbroek@amsterdamumc.nl" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD005291.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/09/08" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005291.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005291.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005291.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abortion, Spontaneous [epidemiology]; *Aneuploidy; Bias; Biopsy; Birth Rate; Blastocyst [pathology]; *Fertilization in Vitro; Genetic Testing [*methods]; Live Birth; Maternal Age; Polar Bodies [pathology]; Preimplantation Diagnosis [*methods]; Randomized Controlled Trials as Topic; *Sperm Injections, Intracytoplasmic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005291.pub3&amp;doi=10.1002/14651858.CD005291.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="jxlIh5Me";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005291\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005291\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa","ko","fr","ms","ja"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005291.pub3",title:"Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation",firstPublishedDate:"Sep 8, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005291.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005291.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005291.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005291.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005291.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005291.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005291.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005291.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005291.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005291.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12103 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005291.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-sec-0111"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-sec-0103"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/appendices#CD005291-sec-0116"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/table_n/CD005291StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/table_n/CD005291StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#CD005291-cr-0004">Simone Cornelisse</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#CD005291-cr-0005">Miriam Zagers</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#CD005291-cr-0006">Elena Kostova</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#CD005291-cr-0007">Kathrin Fleischer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#CD005291-cr-0008">Madelon van Wely</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information#CD005291-cr-0009"><i class="icon corresponding-author fa fa-envelope"></i>Sebastiaan Mastenbroek</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information/en#CD005291-sec-0126">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 08 September 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005291.pub3">https://doi.org/10.1002/14651858.CD005291.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005291-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005291-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005291-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005291-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005291-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005291-abs-0005">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005291-abs-0001" lang="en"> <section id="CD005291-sec-0001"> <h3 class="title" id="CD005291-sec-0001">Background</h3> <p>In in vitro fertilisation (IVF) with or without intracytoplasmic sperm injection (ICSI), selection of the most competent embryo(s) for transfer is based on morphological criteria. However, many women do not achieve a pregnancy even after 'good quality' embryo transfer. One of the presumed causes is that such morphologically normal embryos have an abnormal number of chromosomes (aneuploidies). Preimplantation genetic testing for aneuploidies (PGT‐A), formerly known as preimplantation genetic screening (PGS), was therefore developed as an alternative method to select embryos for transfer in IVF. In PGT‐A, the polar body or one or a few cells of the embryo are obtained by biopsy and tested. Only polar bodies and embryos that show a normal number of chromosomes are transferred. </p> <p>The first generation of PGT‐A, using cleavage‐stage biopsy and fluorescence in situ hybridisation (FISH) for the genetic analysis, was demonstrated to be ineffective in improving live birth rates. Since then, new PGT‐A methodologies have been developed that perform the biopsy procedure at other stages of development and use different methods for genetic analysis. </p> <p>Whether or not PGT‐A improves IVF outcomes and is beneficial to patients has remained controversial. </p> </section> <section id="CD005291-sec-0002"> <h3 class="title" id="CD005291-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of PGT‐A in women undergoing an IVF treatment.</p> </section> <section id="CD005291-sec-0003"> <h3 class="title" id="CD005291-sec-0003">Search methods</h3> <p>We searched the Cochrane Gynaecology and Fertility (CGF) Group Trials Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, and two trials registers in September 2019 and checked the references of appropriate papers. </p> </section> <section id="CD005291-sec-0004"> <h3 class="title" id="CD005291-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs) reporting data on clinical outcomes in participants undergoing IVF with PGT‐A versus IVF without PGT‐A were eligible for inclusion. </p> </section> <section id="CD005291-sec-0005"> <h3 class="title" id="CD005291-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected studies for inclusion, assessed risk of bias, and extracted study data. The primary outcome was the cumulative live birth rate (cLBR). Secondary outcomes were live birth rate (LBR) after the first embryo transfer, miscarriage rate, ongoing pregnancy rate, clinical pregnancy rate, multiple pregnancy rate, proportion of women reaching an embryo transfer, and mean number of embryos per transfer. </p> </section> <section id="CD005291-sec-0006"> <h3 class="title" id="CD005291-sec-0006">Main results</h3> <p>We included 13 trials involving 2794 women. The quality of the evidence ranged from low to moderate. The main limitations were imprecision, inconsistency, and risk of publication bias. </p> <p><b>IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses</b> </p> <p><i>Polar body biopsy</i> </p> <p>One trial used polar body biopsy with array comparative genomic hybridisation (aCGH). It is uncertain whether the addition of PGT‐A by polar body biopsy increases the cLBR compared to IVF without PGT‐A (odds ratio (OR) 1.05, 95% confidence interval (CI) 0.66 to 1.66, 1 RCT, N = 396, low‐quality evidence). The evidence suggests that for the observed cLBR of 24% in the control group, the chance of live birth following the results of one IVF cycle with PGT‐A is between 17% and 34%. It is uncertain whether the LBR after the first embryo transfer improves with PGT‐A by polar body biopsy (OR 1.10, 95% CI 0.68 to 1.79, 1 RCT, N = 396, low‐quality evidence). PGT‐A with polar body biopsy may reduce miscarriage rate (OR 0.45, 95% CI 0.23 to 0.88, 1 RCT, N = 396, low‐quality evidence). No data on ongoing pregnancy rate were available. The effect of PGT‐A by polar body biopsy on improving clinical pregnancy rate is uncertain (OR 0.77, 95% CI 0.50 to 1.16, 1 RCT, N = 396, low‐quality evidence). </p> <p><i>Blastocyst stage biopsy</i> </p> <p>One trial used blastocyst stage biopsy with next‐generation sequencing. It is uncertain whether IVF with the addition of PGT‐A by blastocyst stage biopsy increases cLBR compared to IVF without PGT‐A, since no data were available. It is uncertain if LBR after the first embryo transfer improves with PGT‐A with blastocyst stage biopsy (OR 0.93, 95% CI 0.69 to 1.27, 1 RCT, N = 661, low‐quality evidence). It is uncertain whether PGT‐A with blastocyst stage biopsy reduces miscarriage rate (OR 0.89, 95% CI 0.52 to 1.54, 1 RCT, N = 661, low‐quality evidence). No data on ongoing pregnancy rate or clinical pregnancy rate were available. </p> <p><b>IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis</b> </p> <p>Eleven trials were included in this comparison. It is uncertain whether IVF with addition of PGT‐A increases cLBR (OR 0.59, 95% CI 0.35 to 1.01, 1 RCT, N = 408, low‐quality evidence). The evidence suggests that for the observed average cLBR of 29% in the control group, the chance of live birth following the results of one IVF cycle with PGT‐A is between 12% and 29%. PGT‐A performed with FISH probably reduces live births after the first transfer compared to the control group (OR 0.62, 95% CI 0.43 to 0.91, 10 RCTs, N = 1680, I² = 54%, moderate‐quality evidence). The evidence suggests that for the observed average LBR per first transfer of 31% in the control group, the chance of live birth after the first embryo transfer with PGT‐A is between 16% and 29%. There is probably little or no difference in miscarriage rate between PGT‐A and the control group (OR 1.03, 95%, CI 0.75 to 1.41; 10 RCTs, N = 1680, I² = 16%; moderate‐quality evidence). The addition of PGT‐A may reduce ongoing pregnancy rate (OR 0.68, 95% CI 0.51 to 0.90, 5 RCTs, N = 1121, I² = 60%, low‐quality evidence) and probably reduces clinical pregnancies (OR 0.60, 95% CI 0.45 to 0.81, 5 RCTs, N = 1131; I² = 0%, moderate‐quality evidence). </p> </section> <section id="CD005291-sec-0007"> <h3 class="title" id="CD005291-sec-0007">Authors' conclusions</h3> <p>There is insufficient good‐quality evidence of a difference in cumulative live birth rate, live birth rate after the first embryo transfer, or miscarriage rate between IVF with and IVF without PGT‐A as currently performed. No data were available on ongoing pregnancy rates. The effect of PGT‐A on clinical pregnancy rate is uncertain. </p> <p>Women need to be aware that it is uncertain whether PGT‐A with the use of genome‐wide analyses is an effective addition to IVF, especially in view of the invasiveness and costs involved in PGT‐A. PGT‐A using FISH for the genetic analysis is probably harmful. </p> <p>The currently available evidence is insufficient to support PGT‐A in routine clinical practice. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005291-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005291-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005291-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005291-abs-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005291-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005291-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005291-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005291-abs-0009">Bahasa Malaysia</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005291-abs-0002" lang="en"> <h3>Preimplantation genetic testing for abnormal chromosome numbers for couples undergoing in vitro fertilisation </h3> <p><b>Review question</b> </p> <p>Does preimplantation genetic testing for abnormal chromosome numbers improve the chances of a pregnancy followed by a live‐born baby? </p> <p><b>Background</b> </p> <p>In in vitro fertilisation (IVF) with or without intracytoplasmic sperm injection (ICSI), the selection of the best embryo(s) for transfer is mainly based on morphological assessment of the embryos, which includes the number of cells, the regularity of cells, and the presence of cell fragments. Unfortunately, almost two‐thirds of couples do not get pregnant even after transfer of ‘good quality’ embryos. One of the presumed causes is that such embryos have an abnormal number of chromosomes (aneuploidy). Preimplantation genetic testing for aneuploidy (PGT‐A) is a technique used to analyse the number of chromosomes present in IVF embryos. In PGT‐A, a polar body (a waste product of maternal meiosis),or one or a few cells of the embryo are obtained by biopsy and tested. Only polar bodies or embryos with a normal number of chromosomes in each cell, so‐called 'euploid embryos', are transferred into the uterus. The idea is that this will increase the live birth rate per started IVF cycle. Previous studies on PGT‐A that used a genetic analysis technique called fluorescence in situ hybridisation (FISH) found PGT‐A to be ineffective in improving live birth rates. Since then, new methodologies and techniques in PGT‐A have been developed that perform the procedure on polar bodies or other stages of embryo development and use different methods of genetic analysis (array comparative genomic hybridisation (aCGH) or next‐generation sequencing (NGS)). </p> <p>We compared the benefits and risks of IVF with and without PGT‐A, performed with different techniques at different stages: polar body or other stage of embryo development. </p> <p><b>Study characteristics</b> </p> <p>We included 13 randomised controlled trials (a type of study in which participants are assigned to one of two or more treatment groups using a random method) involving a total of 2794 women. The evidence is current to September 2019. </p> <p><b>Key results</b> </p> <p><i><b>IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses</b> </i> </p> <p><i>Polar body biopsy</i> </p> <p>There was not enough evidence to determine whether there is any difference in the cumulative live birth rate (cLBR) or live birth rate (LBR) after the first embryo transfer with the addition of PGT‐A using polar body biopsy to IVF. There may be a reduction in the miscarriage rate with the addition of PGT‐A. No studies reported on ongoing pregnancy rate. It is also uncertain whether the addition of PGT‐A with polar body biopsy to IVF leads to more clinical pregnancies. </p> <p><i>Blastocyst stage biopsy</i> </p> <p>No studies reported on cLBR after blastocyst stage biopsy. It is uncertain if the addition of PGT‐A with biopsy in the blastocyst stage improves LBR after the first embryo transfer or reduces the miscarriage rate. No studies reported on ongoing pregnancy rate or clinical pregnancy rate. </p> <p><i><b>IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis</b> </i> </p> <p>The addition of PGT‐A by FISH does not increase cLBR where FISH is used for the genetic analysis. Live birth rate after the first embryo transfer is probably reduced by the addition of PGT‐A. There is probably little or no difference in miscarriage rates between IVF with and without PGT‐A using FISH. PGT‐A using FISH may reduce ongoing pregnancies and probably reduces clinical pregnancies. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of the evidence ranged from low to moderate. The main limitations of the evidence were the limited number of studies and events, inconsistency in the estimates between studies, and indications that results may be biased because not all eligible studies have been published. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005291-sec-0111" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005291-sec-0111"></div> <h3 class="title" id="CD005291-sec-0112">Implications for practice</h3> <section id="CD005291-sec-0112"> <p>It is uncertain whether the addition of blastocyst stage preimplantation genetic testing for aneuploidies (PGT‐A) where genome‐wide analyses are used, that is the current standard in routine practice today, improves cumulative live birth rates or reduces miscarriage rate. Evidence based on one trial showed a decrease in miscarriage rate with the use of polar body biopsy. There were no data available on ongoing pregnancy rates. The effect of PGT‐A on the number of clinical pregnancies is also uncertain. </p> <p>The currently available evidence does not support the routine use of PGT‐A with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis. It is uncertain if PGT‐A with the use of FISH improves cumulative live birth rate. PGT‐A with the use of FISH probably decreases live birth rate after the first embryo transfer. There is probably little or no difference in the number of miscarriages between groups. PGT‐A with the use of FISH may reduce ongoing pregnancies and probably reduces the number of clinical pregnancies. </p> <p>Women and partners who receive IVF should have access to up‐to‐date information on the uncertainty of the effectiveness of PGT‐A, especially considering the invasiveness and costs, in order to make informed choices regarding their treatment. The currently available evidence is insufficient to support PGT‐A in routine clinical practice. </p> </section> <h3 class="title" id="CD005291-sec-0113">Implications for research</h3> <section id="CD005291-sec-0113"> <p>Considering the outcomes of our review, new developments should be properly evaluated before their routine clinical application. This involves method assessment studies, pilot‐studies showing a potential benefit in terms of cumulative live birth per woman, followed by randomised controlled trials. New research on the effectiveness of PGT‐A should be specifically directed at retaining the highest cumulative live birth chances whilst preventing miscarriages. Another reason for the need for new research is the low number of new included studies in this update review. Future trials should ideally: randomise the participants before the ovum pick‐up so there is no withdrawal of participants without an embryo transfer; have a clear description of the indication(s) for PGT‐A in the study; include cumulative live birth rate and time to pregnancy as outcomes; and use the right unit of analysis (e.g. per woman, per ovum pick‐up). </p> <p>New research on PGT‐A with the use of FISH for genetic analysis is no longer necessary.</p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005291-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005291-sec-0008"></div> <div class="table" id="CD005291-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Preimplantation genetic testing for aneuploidies with the use genome‐wide analyses in in vitro fertilisation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Preimplantation genetic testing for aneuploidies with the use genome‐wide analyses in in vitro fertilisation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> couples with an in vitro fertilisation indication<br/><b>Settings:</b> fertility clinics<br/><b>Intervention:</b> PGT‐A with the use of genome‐wide analyses </p> <p><b>Comparison:</b> no PGT‐A </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes per woman</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Embryo stage of biopsy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>PGT‐A with the use of genome‐wide analyses</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cumulative live birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>245 per 1000<br/>(169 to 338) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.05<br/>(0.66 to 1.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate after the first embryo transfer</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>199 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>215 per 1000</p> <p>(144 to 308)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.10<br/>(0.68 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Blastocyst stage biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>435 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>417 per 1000</p> <p>(347 to 494)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.93<br/>(0.69 to 1.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>661<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 per 1000<br/>(36 to 127) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.45<br/>(0.23 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Blastocyst stage biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 per 1000</p> <p>(44 to 121)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.89<br/>(0.52 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>661<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported on ongoing pregnancy.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>366 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>308 per 1000<br/>(224 to 402) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.77<br/>(0.50 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>PGT‐A:</b> preimplantation genetic testing for aneuploidies; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision: results based on one study, small number of events; CI crosses the line of no effect.<br/><sup>b</sup>Downgraded two levels for imprecision: results based on one study, small number of events. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005291-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Preimplantation genetic testing for aneuploidies with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis in in vitro fertilisation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Preimplantation genetic testing for aneuploidies with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis in in vitro fertilisation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> couples with an in vitro fertilisation indication<br/><b>Settings:</b> fertility clinics<br/><b>Intervention:</b> PGT‐A with the use of FISH for the genetic analysis </p> <p><b>Comparison:</b> no PGT‐A </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes per woman</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect <br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>PGT‐A with the use of <b>FISH</b> for the genetic analysis </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cumulative live birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>287 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>192 per 1000<br/>(124 to 289) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.59<br/>(0.35 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth rate after the first embryo transfer</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>307 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>215 per 1000<br/>(160 to 287) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.62<br/>(0.43 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000<br/>(81 to 143) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.03<br/>(0.75 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>274 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000<br/>(161 to 253) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.68<br/>(0.51 to 0.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1121<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>219 per 1000<br/>(174 to 267) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.56<br/>(0.42 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1131<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>PGT‐A:</b> preimplantation genetic testing for aneuploidies; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision: results based on one study, small number of events.<br/><sup>b</sup>Downgraded one level for inconsistency: I² &gt; 50% in results across studies.<br/><sup>c</sup>Downgraded one level for imprecision: the CI for most studies crosses the line of no effect, or small number of events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005291-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005291-sec-0009"></div> <section id="CD005291-sec-0010"> <h3 class="title" id="CD005291-sec-0010">Description of the condition</h3> <p>One in six couples experience subfertility, defined as the failure to conceive after one year of unprotected intercourse, at least once during their reproductive lifetime (<a href="./references#CD005291-bbs2-0054" title="DyerS , ChambersGM , deMouzonJ , NygrenKG , Zegers-HochschildF , MansourR , et al. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010. Human Reproduction2016;31(7):1588-609.">Dyer 2016</a>). In vitro fertilisation (IVF) with and without intracytoplasmic sperm injection (ICSI) has evolved as the intervention of choice to help these couples conceive. </p> <p>In IVF, selection of the most competent embryo(s) for transfer is mainly based on morphological criteria, such as the number of pronuclei, the number and regularity of blastomeres, and the percentage of fragmentation in cleavage stage embryos, and assessment of trophectoderm, inner cell mass, and expansion in the blastocyst stage of embryo development. Even so, two‐thirds of women do not reach pregnancy, whilst some others might result in a miscarriage, after transfer of embryos that are morphologically of good quality (<a href="./references#CD005291-bbs2-0049" title="De GeyterC , Calhaz-JorgeC , KupkaMS , WynsC , MocanuE , Mortenko T et al. ART in Europe, 2014: results generated from European registries by ESHRE: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Human Reproduction2018;33(9):1586-01. [DOI: 10.1093/humrep/dey242 ]">De Geyter 2018</a>). </p> <p>One of the suggested causes is that such morphologically normal embryos contain an abnormal number of chromosomes (aneuploidies). Those embryos have been regarded as the main reason for implantation failure, miscarriage, or recurrent miscarriages and prolonged time to pregnancy in IVF. </p> <p>Since the early 1980s, many reports have been published showing numerical chromosome abnormalities in morphologically normal human cleavage stage embryos (<a href="./references#CD005291-bbs2-0037" title="AngellRR , AitkenRJ , Van LookPF , LumsdenMA , TempletonAA . Chromosome abnormalities in human embryos after in vitro fertilization. Nature1983;303(5915):336-8. [DOI: 10.1038/303336a0]">Angell 1983</a>; <a href="./references#CD005291-bbs2-0078" title="MunnéS , WeierHU , GriffoJ , CohenJ . A fast and efficient method for simultaneous X and Y in situ hybridization of human blastomeres. Journal of Assisted Reproduction &amp; Genetics1993;10(1):82-90. [DOI: 10.1007/bf01204446 ]">Munné 1993</a>; <a href="./references#CD005291-bbs2-0041" title="BenadivaCA , KligmanI , MunnéS . Aneuploidy 16 in human embryos increases significantly with maternal age. Fertility and Sterility1996;66:248-55.">Benadiva 1996</a>; <a href="./references#CD005291-bbs2-0052" title="DelhantyJD , HarperJC , AoA , HandysideAH , WinstonRM . Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Human Genetics1997;99:755-60. [DOI: 10.1007/s004390050443 ]">Delhanty 1997</a>). Since aneuploid embryos are not expected to develop to term, preimplantation genetic testing for aneuploidies (PGT‐A) was introduced in 1995 to improve live birth rates (<a href="./references#CD005291-bbs2-0105" title="VerlinskyY , CieslakJ , FreidineM , IvakhnenkoV , WolfG , KovalinskayaL , et al. Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Human Reproduction1995;10(7):1923-27. [DOI: 10.1093/oxfordjournals.humrep.a136207 ] [PMID: 8583011 ]">Verlinsky 1995</a>; <a href="./references#CD005291-bbs2-0096" title="SermonK , CapalboA , CohenJ , CoonenE , De RyckeM , De VosA , et al. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Molecular Human Reproduction2016;22(8):845-57. [DOI: 10.1093/molehr/gaw034 ] [PMID: 27256483]">Sermon 2016</a>). </p> </section> <section id="CD005291-sec-0011"> <h3 class="title" id="CD005291-sec-0011">Description of the intervention</h3> <p>The previous terminology of 'preimplantation genetic screening' (PGS) has been replaced by 'preimplantation genetic testing', or PGT, following a revision of terminology used in infertility care (<a href="./references#CD005291-bbs2-0111" title="Zegers-HochschildF , AdamsonGD , DyerS , RacowskyC , deMouzonJ , SokolR , et al. The International Glossary on Infertility and Fertility Care, 2017. Human Reproduction2017;32:1786-1801. [DOI: 10.1093/humrep/dex234 ]">Zegers‐Hochschild 2017</a>). PGT is defined as a test performed to analyse the DNA from mature oocytes (polar bodies) or embryos (cleavage or blastocyst stage) for determining genetic abnormalities. This includes PGT for chromosomal structural rearrangements (PGT‐SR), PGT for monogenic/single‐gene defects (PGT‐M), and PGT for aneuploidies (PGT‐A). Although the technology used in PGT‐A and PGT‐SR is nearly identical, PGT‐A and PGT‐SR have completely different indications. PGT‐A aims to improve treatment outcome in subfertile couples undergoing an IVF treatment, whereas PGT‐M and PGT‐SR aim to prevent the birth of affected children in fertile couples with a high risk of transmitting genetic disorders. </p> <p>In PGT‐A, embryos created in vitro are analysed for aneuploidies, and only those that show a normal number of chromosomes, that is those that are euploid for the chromosomes tested, are transferred into the uterine cavity. There are different approaches to obtain nuclear material for this genetic analysis. </p> <p>One approach is aspiration of the first and second polar body from the unfertilised oocyte or the zygote (<a href="./references#CD005291-bbs2-0105" title="VerlinskyY , CieslakJ , FreidineM , IvakhnenkoV , WolfG , KovalinskayaL , et al. Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Human Reproduction1995;10(7):1923-27. [DOI: 10.1093/oxfordjournals.humrep.a136207 ] [PMID: 8583011 ]">Verlinsky 1995</a>; <a href="./references#CD005291-bbs2-0077" title="MontagM , Van der VenK , RosingB , Van der VenH . Polar body biopsy: a viable alternative to preimplantation genetic diagnosis and screening. Reproductive Biomedicine Online2009;18(1 Suppl 1):6-11. [DOI: 10.1016/s1472-6483(10)60109-5 ]">Montag 2009</a>; <a href="./references#CD005291-bbs2-0057" title="GeraedtsJ , SermonK . Preimplantation genetic screening 2.0: the theory. Molecular Human Reproduction2016;22(8):539-544. [DOI: 10.1093/molehr/gaw033. ]">Geraedts 2016</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). Polar bodies are a waste product of maternal meiosis. Mitotic errors and paternally derived meiotic errors and mutations cannot be detected from polar bodies. Polar body biopsy can be an alternative to embryo biopsy due to regulations that prohibit embryo biopsy in specific regions. Another approach is removal of one or two blastomeres from embryos at the early cleavage stage (<a href="./references#CD005291-bbs2-0064" title="HandysideAH , PattinsonJK , PenkethRJ , DelhantyJD , WinstonRM , TuddenhamEG . Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet1989;18(8634):347-9. [DOI: 10.1016/s0140-6736(89)91723-6 ]">Handyside 1989</a>). A third approach is removal of trophectoderm cells at the blastocyst stage (<a href="./references#CD005291-bbs2-0053" title="DokrasA , SargentIL , RossC , GardnerRL , BarlowDH . Trophectoderm biopsy in human blastocysts. Human Reproduction1990;5(7):821-5. [DOI: 10.1093/oxfordjournals.humrep.a137191 ]">Dokras 1990</a>). The amount of DNA is higher since multiple cells are analysed. Finally, new sources of embryonic genetic material can be obtained by blastocyst fluid aspiration, <a href="./references#CD005291-bbs2-0058" title="GianaroliL , MagliMC , PomanteA , CrivelloAM , CafueriG , ValerioM , et al. Blastocentesis: a source of DNA for pre implantation genetic testing. Results from a pilot study. Fertility and Sterility2014;102:1692–99.">Gianaroli 2014</a>; <a href="./references#CD005291-bbs2-0044" title="CapalboA , RomanelliV , PatassiniC , PoliM , GirardiL , GiancaniA , et al. Diagnostic efficacy of blastocoel fluid and spent media as sources of DNA for preimplantation genetic testing in standard clinical conditions. Fertility and Sterility2018;110(5):870-79. [DOI: 10.1016/j.fertnstert.2018.05.031]">Capalbo 2018</a>, or spent embryo culture medium analysis, where cell‐free genomic DNA is obtained (in a non‐invasive way) from the embryo culture medium, may potentially be used for genetic testing (<a href="./references#CD005291-bbs2-0063" title="HammondER , McGillivrayBC , WickerSM , PeekJC , ShellingAN , StoneP , et al. Characterizing nuclear and mitochondrial DNA in spent embryo culture media: genetic contamination identified. Fertility and Sterility2017;107(1):220-8. [DOI: 10.1016/j.fertnstert.2016.10.015.]">Hammond 2017</a>; <a href="./references#CD005291-bbs2-0104" title="Vera-RodriguezM , Diez-JuanA , Jimenez-AlmazanJ , MartinezS , NavarroR , PeinadoV , et al. Origin and composition of cell-free DNA in spent medium from human embryo culture during preimplantation development. Human Reproduction2018;33(4):745-56. [DOI: 10.1093/humrep/dey028] [PMID: 29471395]">Vera‐Rodriquez 2018</a>; <a href="./references#CD005291-bbs2-0040" title="BelandresD , ShamonkiM , NabilA . Current status of spent embryo media research for preimplantation genetic testing. Journal of Assisted Reproduction and Genetics2019;36(5):819-26. [DOI: 10.1007/s10815-019-01437-6]">Belandres 2019</a>; <a href="./references#CD005291-bbs2-0069" title="LeaverM , WellsD . Non-invasive preimplantation genetic testing (niPGT): the next revolution in reproductive genetics?Human Reproduction Update2020;26(1):16-42. [DOI: 10.1093/humupd/dmz033]">Leaver 2020</a>). </p> <p>The method of genetic analysis can be limited to a certain number of chromosomes, mostly when using fluorescence in situ hybridisation (FISH) for the analysis, or it can encompass almost all or all chromosomes in genome‐wide technologies. FISH technology is based on the use of specific DNA probes that are labelled with distinctive fluorochromes; following hybridisation, results are visualised via fluorescence microscopy. Multiple genome‐wide technologies are described; array‐based comparative genomic hybridisation (aCGH) (<a href="./references#CD005291-bbs2-0107" title="WellsD , AlfarawatiS , FragouliE . Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Molecular Human Reproduction2008;14(12):703-10. [DOI: 10.1093/molehr/gan062 ] [PMID: 18957518 ]">Wells 2008</a>; <a href="./references#CD005291-bbs2-0056" title="GeraedtsJ , MontagM , MagliMC , ReppingS , HandysideA , StaessenC , et al. Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results. Human Reproduction2011;26(3):3173-80. [DOI: 10.1093/humrep/der294 ]">Geraedts 2011</a>), single nucleotide polymorphism (SNP) array (<a href="./references#CD005291-bbs2-0103" title="vanUumCM , StevensSJ , DreesenJC , DrüsedauM , SmeetsHJ , Hollanders-CrombachB , et al. SNP array-based copy number and genotype analyses for preimplantation genetic diagnosis of human unbalanced translocations. European Journal of Human Genetics2012;20:938-44. [DOI: 10.1038/ejhg.2012.27]">van Uum 2012</a>), or next generation sequencing (NGS) (<a href="./references#CD005291-bbs2-0100" title="TreffNR , FedickA , TaoX , DevkotaB , TaylorD , ScottRT . Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertility and Sterility2013;99(5):1377-84. [DOI: 10.1016/j.fertnstert.2012.12.018 ] [PMID: 23312231]">Treff 2013</a>). The principle of aCGH is a molecular cytogenetic technique for the detection of chromosomal copy number changes. aCGH compares the genome against a reference DNA sample, utilising the same principles as FISH. The application of NGS for the detection of copy number changes differs from aCGH by using direct reads of genomic sequencing fragments and their quantification according to sequence read numbers instead of a signal intensity comparison between fluorescently labelled test and reference DNA samples. </p> <p>PGT‐A was first recommended and carried out for the following indications: advanced maternal age (<a href="./references#CD005291-bbs2-0017" title="GianaroliL , MagliMC , FerrarettiAP , MunneS . Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertility and Sterility1999;72(5):837-8. ">Gianaroli 1999</a>; <a href="./references#CD005291-bbs2-0079" title="MunnéS , MagliMC , CohenJ , MortonP , SadowyS , GianaroliL , et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Human Reproduction1999;14(9):2191-9. [DOI: 10.1093/humrep/14.9.2191 ]">Munné 1999</a>; <a href="./references#CD005291-bbs2-0067" title="KahramanS , BahceM , SamliH , ImirzaliogluN , YakisnK , CengizG , et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Human Reproduction2000;15(9):2003-7. [DOI: 10.1093/humrep/15.9.2003]">Kahraman 2000</a>; <a href="./references#CD005291-bbs2-0082" title="ObasajuM , KadamA , BiancardiT , SultanK , FatehM , MunnéS . Pregnancies from single normal embryo transfer in women older than 40 years. Reproductive Biomedicine Online2001;2(2):98-101. [DOI: 10.1016/s1472-6483(10)62232-8 ]">Obasaju 2001</a>; <a href="./references#CD005291-bbs2-0080" title="MunnéS , SandalinasM , EscuderoT , VelilaE , WalmsleyR , SadowyS , et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reproductive Biomedicine Online2003;7(1):91-7. [DOI: 10.1016/s1472-6483(10)61735-x ]">Munné 2003</a>; <a href="./references#CD005291-bbs2-0076" title="MontagM , Van der VenK , DornC , Van der VenH . Outcome of laser-assisted polar body biopsy and aneuploidy testing. Reproductive Biomedicine Online2004;9(4):425-9. [DOI: 10.1016/s1472-6483(10)61278-3 ]">Montag 2004</a>; <a href="./references#CD005291-bbs2-0088" title="PlatteauP , StaessenC , MichielsA , Van SteirteghemA , LiebaersI , DevroeyP . Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. Fertility and Sterility2005;84(2):319-24. [DOI: 10.1016/j.fertnstert.2005.02.019 ]">Platteau 2005</a>), repeated IVF failure (<a href="./references#CD005291-bbs2-0017" title="GianaroliL , MagliMC , FerrarettiAP , MunneS . Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertility and Sterility1999;72(5):837-8. ">Gianaroli 1999</a>; <a href="./references#CD005291-bbs2-0067" title="KahramanS , BahceM , SamliH , ImirzaliogluN , YakisnK , CengizG , et al. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Human Reproduction2000;15(9):2003-7. [DOI: 10.1093/humrep/15.9.2003]">Kahraman 2000</a>; <a href="./references#CD005291-bbs2-0080" title="MunnéS , SandalinasM , EscuderoT , VelilaE , WalmsleyR , SadowyS , et al. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reproductive Biomedicine Online2003;7(1):91-7. [DOI: 10.1016/s1472-6483(10)61735-x ]">Munné 2003</a>; <a href="./references#CD005291-bbs2-0085" title="PehlivanT , RubioC , RodrigoL , RomeroJ , RemohiJ , SimonC , et al. Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients. Reproductive Biomedicine Online2003;6(2):232-7. [DOI: 10.1016/s1472-6483(10)61715-4 ]">Pehlivan 2003</a>; <a href="./references#CD005291-bbs2-0108" title="WildingM , FormanR , HogewindG , Di MatteoL , ZulloF , CappielloF , et al. Preimplantation genetic diagnosis for the treatment of failed in vitro fertilization embryo transfer and habitual abortion. Fertility and Sterility2004;891(5):1302-7. [DOI: 10.1016/j.fertnstert.2003.10.028 ]">Wilding 2004</a>), recurrent miscarriage (<a href="./references#CD005291-bbs2-0086" title="PellicerA , RubioC , VidalF , MinguezY , GimenezC , EgozcueJ , et al. In vitro fertilization plus preimplantation genetic diagnosis in patients with recurrent miscarriage: an analysis of chromosome abnormalities in human preimplantation embryos. Fertility and Sterility1999;71(6):1033-9. [DOI: 10.1016/s0015-0282(99)00143-0 ]">Pellicer 1999</a>; <a href="./references#CD005291-bbs2-0093" title="RubioC , SimonC , VidalF , RodrigoL , PehlivanT , RemohiJ , et al. Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Human Reproduction2003;18(1):192-8. [DOI: 10.1093/humrep/deg015 ]">Rubio 2003</a>; <a href="./references#CD005291-bbs2-0081" title="MunnéS , ChenS , FischerJ , CollsP , ZhengX , StevensJ , et al. Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertility and Sterility2005;84(2):331-5. [DOI: 10.1016/j.fertnstert.2005.02.027 ]">Munné 2005</a>; <a href="./references#CD005291-bbs2-0094" title="RubioC , PehlivanT , RodrigoL , SimonC , RemohiJ , PellicerA . Embryo aneuploidy screening for unexplained recurrent miscarriage: a minireview. American Journal of Reproductive Immunology2005;53(4):159-65. [DOI: 10.1111/j.1600-0897.2005.00260.x ]">Rubio 2005</a>), and severe male factor (<a href="./references#CD005291-bbs2-0097" title="SilberS , EscuderoT , LenahanK , AbdelhadiI , KilaniA , MunnéS . Chromosomal abnormalities in embryos derived from testicular sperm extraction. Fertility and Sterility2003;79(1):30-8. [DOI: 10.1016/s0015-0282(02)04407-2]">Silber 2003</a>; <a href="./references#CD005291-bbs2-0087" title="PlatteauP , StaessenC , MichielsA , TournayeH , Van SteirteghemA , LiebaersI , et al. Comparison of the aneuploidy frequency in embryos derived from testicular sperm extraction in obstructive azoospermic men. Human Reproduction2004;19(7):1570-4.">Platteau 2004</a>). Later PGT‐A was also offered to younger women with a good prognosis for a pregnancy, as high aneuploidy rates were found in their embryos as well (<a href="./references#CD005291-bbs2-0039" title="BaartEB , MartiniE , Van den BergI , MacklonNS , GaljaardRJ , FauserBC , et al. Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Human Reproduction2006;21(1):223-33. [DOI: 10.1093/humrep/dei291]">Baart 2006</a>; <a href="./references#CD005291-bbs2-0059" title="GoossensV , HartonG , MoutouC , Traeger-SynodinosJ , Van RijM , HarperJC . ESHRE PGD Consortium data collection IX: cycles from January to December 2006 with pregnancy follow-up to October 2007. Human Reproduction2009;24(8):1786-810. [DOI: 10.1093/humrep/dep059]">Goossens 2009</a>). </p> </section> <section id="CD005291-sec-0012"> <h3 class="title" id="CD005291-sec-0012">How the intervention might work</h3> <p>Initially PGT‐A was introduced based on the hypothesis that selection of an aneuploid embryo from a cohort of embryos available for transfer in an IVF treatment would lead to better clinical outcomes (<a href="./references#CD005291-bbs2-0105" title="VerlinskyY , CieslakJ , FreidineM , IvakhnenkoV , WolfG , KovalinskayaL , et al. Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Human Reproduction1995;10(7):1923-27. [DOI: 10.1093/oxfordjournals.humrep.a136207 ] [PMID: 8583011 ]">Verlinsky 1995</a>). Part of the embryos available in IVF were reported to be aneuploid, and aneuploidies were expected to result in arrested development, implantation failure, or miscarriage (<a href="./references#CD005291-bbs2-0109" title="WiltonL . Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat Diagn2002;22(6):512-18. [DOI: 10.1002/pd.388]">Wilton 2002</a>). Nowadays, the main reason for choosing to use PGT‐A is the hypothesis that PGT‐A could reduce the chance of miscarriage and shorten time to pregnancy leading to live birth (<a href="./references#CD005291-bbs2-0096" title="SermonK , CapalboA , CohenJ , CoonenE , De RyckeM , De VosA , et al. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Molecular Human Reproduction2016;22(8):845-57. [DOI: 10.1093/molehr/gaw034 ] [PMID: 27256483]">Sermon 2016</a>; <a href="./references#CD005291-bbs2-0046" title="CimadomoD , RienziL , CapalboA , RubioC , InnocentiF , García-PascualC , et al. The dawn of the future: 30 years from the first biopsy of a human embryo. The detailed history of an ongoing revolution. Human Reproduction Update2020;26(4):453-473. [DOI: https://doi.org/10.1093/humupd/dmaa019 ]">Cimadomo 2020</a>). PGT‐A can never increase the cumulative live birth rate, as it selects out the aneuploid embryos that would likely not have resulted in a pregnancy (<a href="./references#CD005291-bbs2-0084" title="PaulsonRJ . Preimplantation genetic screening: what is the clinical efficiency?Fertility and Sterility2017;108(2):228-30. [DOI: 10.1016/j.fertnstert.2017.06.023]">Paulson 2017</a>). </p> <p>First‐generation PGT‐A was characterised by biopsy at the cleavage stage of embryo development using fluorescence in situ hybridisation (FISH) for the genetic analysis; however, it was demonstrated to be ineffective in improving IVF live birth rates and reducing miscarriage rates (<a href="./references#CD005291-bbs2-0101" title="TwiskM , MastenbroekS , vanWelyM , HeinemanMJ , Van der VeenF , ReppingS . Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD005291. [DOI: 10.1002/14651858.CD005291.pub2]">Twisk 2006</a>; <a href="./references#CD005291-bbs2-0073" title="MastenbroekS , TwiskM , van derVeenF , ReppingS . Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Human Reproduction Update2011;17(4):454-66. [DOI: 10.1093/humupd/dmr003]">Mastenbroek 2011</a>). The mosaic nature of human preimplantation embryos, which means that not all cells of an embryo have the same chromosomal constitution, and the limited capability and accuracy of the FISH analysis, are considered the main reasons for this failure (<a href="./references#CD005291-bbs2-0095" title="ScrivenPN , BossuytPM . Diagnostic accuracy: theoretical models for preimplantation genetic testing of a single nucleus using the fluorescence in situ hybridization technique. Hum Reprod2010;25(10):2622-2628. [DOI: 10.1093/humrep/deq196]">Scriven 2010</a>; <a href="./references#CD005291-bbs2-0102" title="vanEchten-ArendsJ , MastenbroekS , Sikkema-RaddatzB , KorevaarJC , HeinemanMJ , van derVeenF , et al. Chromosomal mosaicism in human preimplantation embryos: a systematic review. Human Reproduction Update2011;17(5):620-27. [DOI: 10.1093/humupd/dmr014]">van Echten‐Arends 2011</a>; <a href="./references#CD005291-bbs2-0074" title="MastenbroekS , ReppingS . Preimplantation genetic screening: back to the future. Hum Reprod2014;29(9):1846-50. [DOI: 10.1093/humrep/deu163]">Mastenbroek 2014</a>; <a href="./references#CD005291-bbs2-0099" title="TaylorTH , GitlinSA , PatrickJL , CrainJL , WilsonJM , GriffinDK . The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. Hum Reprod Update2014;20(4):571-81. [DOI: 10.1093/humupd/dmu016]">Taylor 2014</a>). Consequently, PGT‐A at the blastocyst stage with the use of genome‐wide analyses became common practice, as mosaicism was claimed to be less of a problem at later stages of embryo development, or could at least be noticed as multiple cells are available for the analysis at the blastocyst stage, and genome‐wide analyses were claimed to be more accurate. </p> <p>PGT‐A and IVF is a controversial subject, as evidence has appeared undermining the rationale of PGT‐A (<a href="./references#CD005291-bbs2-0092" title="RosenwaksZ , HandysideAH , FiorentinoF , GleicherN , PaulsonRJ , SchattmanGL , et al. The pros and cons of preimplantation genetic testing for aneuploidy: clinical and laboratory perspectives. Fertily and Sterility2018;110(3):353-61.">Rosenwaks 2018</a>; <a href="./references#CD005291-bbs2-0075" title="MochizukiL , GleicherN . The PGS/PGT-A controversy in IVF addressed as a formal conflict resolution analysis. J Assist Reprod Genet2020;37(3):677-678. [DOI: 10.1007/s10815-020-01688-8]">Mochizuki 2020</a>). It was demonstrated that mosaic embryos could also lead to healthy babies (<a href="./references#CD005291-bbs2-0061" title="GrecoE , MinasiMG , FiorentinoF . Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. New England Journal of Medicine2015;373:2089-90. [DOI: 10.1056/NEJMc1500421]">Greco 2015</a>). Subsequently it was proposed that mosaic embryos, which till then were in most cases discarded, could now be transferred to the uterus, although perhaps with a lower priority than euploid embryos (<a href="./references#CD005291-bbs2-0048" title="CramDS , LeighS , HandysideA , RechitskyL , XuK , HartonG , et al. PGDIS Position Statement on the Transfer of Mosaic Embryos 2019. Reproductive BioMedicine Online2019;39:e1-4. [DOI: 10.1016/j.rbmo.2019.06.012]">Cram 2019</a>). An assumed reason is that there is a self‐correction process of aneuploidies in preimplantation embryos, allowing mosaic embryos to result in healthy live births, although perhaps with lower efficiency than fully euploid embryos (<a href="./references#CD005291-bbs2-0043" title="BoltonH , GrahamSJL , Van der AaN , KumarP , TheunisK , FernandezE , et al. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nature Communications2016;7:11165. [DOI: 10.1038/ncomms11165]">Bolton 2016</a>; <a href="./references#CD005291-bbs2-0098" title="SinglaS , Iwamoto-StohlLK , ZhuM , Zernicka-GoetzM . Autophagy-mediated apoptosis eliminates aneuploid cells in a mouse model of chromosome mosaicism. Nature Communications2020;11:2958. [DOI: 10.1038/s41467-020-16796-3]">Singla 2020</a>). But next to mosaicism, there is still a debate surrounding the accuracy of analysis methods, not only since healthy live births have been reported after transfer of aneuploid embryos (<a href="./references#CD005291-bbs2-0083" title='PatrizioP , ShohamG , ShohamZ , LeongM , BaradDH , GleicherN . Worldwide live births following the transfer of chromosomally "Abnormal" embryos after PGT/A: results of a worldwide web-based survey. Journal Assisted Reproductive Genetics2019;36(8):1599-1607. [DOI: 10.1007/s10815-019-01510-0]'>Patrizio 2019</a>), but also since there is increasing evidence that the genome‐wide analyses currently being used have a high false‐positive rate (<a href="./references#CD005291-bbs2-0089" title="PopovicM , DheedeneA , ChristodoulouC , TaelmanJ , DhaenensL , Van NieuwerburghF , et al. Chromosomal mosaicism in human blastocysts: the ultimate challenge of preimplantation genetic testing?Humun Reproduction2018;33(7):1342-54. [DOI: 10.1093/humrep/dey106]">Popovic 2018</a>; <a href="./references#CD005291-bbs2-0068" title="LawrenzB , El KhatibI , LiñánA , BayramA , ArnanzA , ChopraR , et al. The clinicians' dilemma with mosaicism - an insight from inner cell mass biopsies. Human Reproduction2019;34(6):998-1010. [DOI: 10.1093/humrep/dez055]">Lawrenz 2019</a>; <a href="./references#CD005291-bbs2-0090" title="PopovicM , DhaenensL , BoelA , MentenB , HeindryckxB . Chromosomal mosaicism in human blastocysts: the ultimate diagnostic dilemma. Human Reproduction Update2020;26(3):313-34. [DOI: 10.1093/humupd/dmz050]">Popovic 2020</a>). </p> </section> <section id="CD005291-sec-0013"> <h3 class="title" id="CD005291-sec-0013">Why it is important to do this review</h3> <p>It has been demonstrated that the former approach for PGT‐A, that is cleavage stage biopsy with the use of FISH for genetic analysis, is ineffective in improving IVF live birth rates and in reducing miscarriage rates (<a href="./references#CD005291-bbs2-0101" title="TwiskM , MastenbroekS , vanWelyM , HeinemanMJ , Van der VeenF , ReppingS . Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD005291. [DOI: 10.1002/14651858.CD005291.pub2]">Twisk 2006</a>). New approaches of PGT‐A have been developed that perform the procedure on polar bodies or other stages of embryo development and use different methods of genetic analysis. </p> <p>These new approaches of PGT‐A have been introduced into routine clinical practice and are often offered; however, their effectiveness remains unclear (<a href="./references#CD005291-bbs2-0074" title="MastenbroekS , ReppingS . Preimplantation genetic screening: back to the future. Hum Reprod2014;29(9):1846-50. [DOI: 10.1093/humrep/deu163]">Mastenbroek 2014</a>). We therefore undertook and updated this systematic review to investigate whether there is a difference in cumulative live birth rate, live birth per first embryo transfer, miscarriage rate, ongoing pregnancy rate, or clinical pregnancy rate. This involved comparing IVF with PGT‐A versus IVF without PGT‐A. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005291-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005291-sec-0014"></div> <p>To evaluate the effectiveness and safety of PGT‐A in women undergoing an IVF treatment.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005291-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005291-sec-0015"></div> <section id="CD005291-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005291-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCT) were eligible for inclusion in the review. We excluded non‐randomised studies and quasi‐randomised trials. We also excluded cross‐over trials, which are not appropriate in this context. </p> <p>Due to bias by design in favour of PGT‐A, we excluded RCTs that only reported results on women reaching a euploid embryo transfer, studies where PGT‐A was not performed on the full cohort of embryos, and studies where multiple oocyte retrievals were allowed before a transfer was attempted without the possibility to extract data per ovum pick‐up. </p> </section> <section id="CD005291-sec-0018"> <h4 class="title">Types of participants</h4> <p>Women undergoing IVF treatment with or without PGT‐A offered for all suggested indications or a combination of indications, that is: </p> <p> <ul id="CD005291-list-0001"> <li> <p>advanced maternal age (AMA);</p> </li> <li> <p>repeated IVF failure (RIF);</p> </li> <li> <p>recurrent miscarriage;</p> </li> <li> <p>testicular sperm extraction (TESE‐ICSI);</p> </li> <li> <p>good‐prognosis patients.</p> </li> </ul> </p> </section> <section id="CD005291-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We compared IVF with PGT‐A versus IVF without PGT‐A.</p> <p>We included the following two randomised comparisons.</p> <p> <ol id="CD005291-list-0002"> <li> <p>IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses</p> </li> <li> <p>IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis</p> </li> </ol> </p> <p>In these two randomised comparisons, different subgroups exist between the moment of biopsy in embryo development, as follows. </p> <p> <ol id="CD005291-list-0003"> <li> <p>Polar body biopsy</p> </li> <li> <p>Cleavage stage biopsy</p> </li> <li> <p>Blastocyst stage biopsy</p> </li> </ol> </p> </section> <section id="CD005291-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD005291-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD005291-list-0004"> <li> <p>Cumulative live birth rate per woman, defined as the birth of a living child after 20 weeks of gestation, after one IVF cycle, including the results of cryopreserved thawed embryo transfers. </p> </li> </ul> </p> </section> <section id="CD005291-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD005291-list-0005"> <li> <p>Live birth rate per woman after the first embryo transfer, defined as the birth of a living child after 20 weeks of gestation after the first embryo transfer in an IVF cycle. </p> </li> <li> <p>Miscarriage rate per woman and per pregnancy.</p> </li> <li> <p>Ongoing pregnancy per woman, defined as ultrasound‐confirmed evidence of a gestation sac with fetal heart motion at 12 weeks. </p> </li> <li> <p>Clinical pregnancy per woman, defined by the presence of an intrauterine gestational sac or the presence of intrauterine gestational sac with fetal heartbeat. </p> </li> <li> <p>Multiple pregnancy per woman and per live birth.</p> </li> <li> <p>Proportion of women reaching embryo transfer.</p> </li> <li> <p>Mean number of embryos per transfer.</p> </li> </ul> </p> </section> </section> </section> <section id="CD005291-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all published and unpublished RCTs on PGT‐A versus non‐PGT‐A, with no language or date restriction and in consultation with the Cochrane Gynaecology and Fertility Group (CGF) Information Specialist. </p> <section id="CD005291-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases for relevant trials:</p> <p> <ul id="CD005291-list-0006"> <li> <p>the Cochrane Gynaecology and Fertility Group (CGF) Specialised Register of Controlled Trials; ProCite platform, searched on 9 September 2019 (<a href="./appendices#CD005291-sec-0117">Appendix 1</a>); </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL); Ovid platform, searched on 9 September 2019 (Issue August 2019) (<a href="./appendices#CD005291-sec-0118">Appendix 2</a>); </p> </li> <li> <p>MEDLINE Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations; Ovid platform, searched from 1946 to 9 September 2019 (<a href="./appendices#CD005291-sec-0119">Appendix 3</a>); </p> </li> <li> <p>Embase; Ovid platform, searched from 1980 to 9 September 2019 (<a href="./appendices#CD005291-sec-0120">Appendix 4</a>); </p> </li> <li> <p>PsycINFO; Ovid platform, searched from 1806 to 9 September 2019 (<a href="./appendices#CD005291-sec-0121">Appendix 5</a>); </p> </li> <li> <p>CINAHL (Cumulative Index to Nursing and Allied Health Literature); EBSCO platform, searched from 1961 to 9 September 2019 (<a href="./appendices#CD005291-sec-0122">Appendix 6</a>). </p> </li> </ul> </p> <p>We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Chapter 6, 6.4.11; <a href="./references#CD005291-bbs2-0070" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. In: Available from handbook.cochrane.org.">Lefebvre 2011</a>). The Embase, PsycINFO, and CINAHL searches are combined with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<a href="https://eur04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.sign.ac.uk%2Fwhat-we-do%2Fmethodology%2Fsearch-filters%2F&amp;data=02%7C01%7Ce.b.kostova%40amsterdamumc.nl%7C775a6ff36025432649e408d84d446a07%7C68dfab1a11bb4cc6beb528d756984fb6%7C0%7C0%7C637344303530122110&amp;sdata=Fx%2F%2BkRsVZRp5vVCWRUMjtTo4EUeLW6y2kso6rNj9g6Q%3D&amp;reserved=0" target="_blank">www.sign.ac.uk/what-we-do/methodology/search-filters/</a>). </p> <p>We also searched the following other electronic sources of trials.</p> <p> <ul id="CD005291-list-0007"> <li> <p>Trial registers for ongoing and registered trials, searched on 9 September 2019:</p> </li> </ul> </p> <p> <ul class="plain" id="CD005291-list-0008"> <li> <ul id="CD005291-list-0009"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">www.who.int/trialsearch/Default.aspx</a>). </p> </li> </ul> </li> </ul> </p> <p>Note: it is now mandatory for Cochrane Reviews to include searches of trial registers.</p> <p> <ul id="CD005291-list-0010"> <li> <p>LILACS (Latin American and Caribbean Health Science Information database; from 1982 to 9 September 2019) and other Spanish and Portuguese language databases found in the Virtual Health Library Regional Portal (VHL) (<a href="http://bvsalud.org/portal/?lang=en" target="_blank">bvsalud.org/portal/?lang=en</a>) (the right‐hand drop down box allows you to filter out MEDLINE records). </p> </li> </ul> </p> </section> <section id="CD005291-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the following conference abstracts:</p> <p> <ul id="CD005291-list-0011"> <li> <p>American Society for Reproductive Medicine and Canadian Fertility and Andrology Society (ASRM/CFAS) Conjoint Annual Meeting (2018), Abstracts of the Scientific Oral and Poster Sessions, Program Supplement; </p> </li> <li> <p>European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting (2018), Abstracts of the Scientific Oral and Poster Sessions, Program Supplement. </p> </li> </ul> </p> <p>We handsearched the references cited in all obtained studies. We searched PubMed and Google for any recent trials that had not yet been indexed in MEDLINE. </p> <p>We contacted experts in the field to obtain additional data. We contacted original authors for clarification and further data if the trial report was unclear. </p> <p>We did not perform a separate search for adverse effects of PGT‐A. We considered adverse effects described in the studies only. </p> </section> </section> <section id="CD005291-sec-0026"> <h3 class="title" id="CD005291-sec-0026">Data collection and analysis</h3> <section id="CD005291-sec-0027"> <h4 class="title">Selection of studies</h4> <p>After an initial screen of titles and abstracts retrieved by the search, conducted by the CGF Information Specialist (Marian Showell), two review authors (SC and MZ) retrieved the full texts of all potentially eligible studies. We used the software program Covidence to manage the screening of titles and abstracts and to generate the PRISMA flow diagram (<a href="./references#CD005291-bbs2-0047" title="Veritas Health InnovationCovidence. Version accessed 14 September 2019. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.">Covidence</a>). Two review authors (SC and MZ) independently examined the full texts against the inclusion criteria to determine their eligibility. In the case of disagreement between review authors, a third review author (SM) was consulted to establish consensus on whether to include the trial or not. We documented the selection process with a PRISMA flow chart (<a href="#CD005291-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD005291-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD005291-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD005291-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (SC and MZ) independently extracted the outcome data and information on location, clinical and design details, funding, and participants. In the case of disagreement between review authors, a third review author (SM) was consulted to establish consensus. Any differences were resolved by discussion. Details of the studies are provided in the <a href="./references#CD005291-sec-0132" title="">Characteristics of included studies</a> tables. Studies that appeared to meet the inclusion criteria but were excluded from the review are presented in the <a href="./references#CD005291-sec-0133" title="">Characteristics of excluded studies</a> tables along with the reasons for their exclusion in brief. </p> </section> <section id="CD005291-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (SC and MZ) independently assessed the included studies for risk of bias using the Cochrane 'Risk of bias' tool (<a href="./references#CD005291-bbs2-0066" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). The tool addresses the following domains: </p> <p> <ul id="CD005291-list-0012"> <li> <p>selection bias (random sequence generation, allocation concealment);</p> </li> <li> <p>performance bias (blinding of participants and personnel);</p> </li> <li> <p>detection bias (blinding of outcome assessors);</p> </li> <li> <p>attrition bias (incomplete outcome data);</p> </li> <li> <p>reporting bias (selective reporting);</p> </li> <li> <p>other forms of bias such as selective reporting of subgroups, or potential influence from funders. </p> </li> </ul> </p> <p>In case of disagreement between review authors, a third review author (EK) was consulted to establish consensus. We assigned judgements to each of these domains, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005291-bbs2-0066" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). Special attention was given to selective reporting, as it affects the internal validity of an individual study. Studies might not present data per woman starting an IVF cycle. This information is described in the <a href="./references#CD005291-sec-0132" title="">Characteristics of included studies</a> table and <a href="#CD005291-fig-0002">Figure 2</a> and <a href="#CD005291-fig-0003">Figure 3</a> and provides a context for discussing the reliability of the results. Our conclusions are presented in the 'Risk of bias' table. </p> <div class="figure" id="CD005291-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005291-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005291-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005291-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD005291-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>All of our outcomes represented dichotomous data (e.g. live birth rates). We used the numbers of events in the control and intervention groups of each study to calculate Mantel‐Haenszel odds ratios (ORs). We reversed the direction of effect of individual studies if required to ensure consistency across trials. We used mean difference (MD) for continuous outcomes. We presented 95% confidence intervals (CIs) for all outcomes. We assessed whether the estimates calculated in the review for individual studies were compatible in each case with the estimates reported in the study publications. </p> </section> <section id="CD005291-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We analysed the data per woman randomised. We also analysed per clinical pregnancy for miscarriage. Data that did not permit valid analysis (e.g. per woman or per ovum pick‐up) were excluded. We counted multiple pregnancy as one event; this outcome was also analysed per live birth. </p> </section> <section id="CD005291-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We analysed the data on an intention‐to‐treat (ITT) basis as far as possible (i.e. including all randomised participants in the analysis in the groups to which they had been randomised). We anticipated that trials conducted over 10 years ago might not have data on cumulative live birth rates. When there was insufficient information in the published report, we attempted to contact the authors of the included studies for clarification. If missing data became available, we included these in the analysis. When we were unable to obtain these data, we undertook imputation of individual values for cumulative live birth rate and live birth rate per first embryo transfer only. Live birth was assumed not to have occurred in participants without a reported outcome. For other outcomes, we analysed only the available data. </p> </section> <section id="CD005291-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta‐analysis to provide a meaningful summary. We assessed statistical heterogeneity by measuring the I² statistic. We assumed that there was substantial heterogeneity when I² was calculated as greater than 50% (<a href="./references#CD005291-bbs2-0066" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> </section> <section id="CD005291-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned that if more than 10 studies were identified, we would produce a funnel plot to evaluate the risk of reporting bias, to explore the possibility of small‐study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies) (<a href="./references#CD005291-bbs2-0045" title="ChaimaniA , HigginsJPT , MavridisD , SpyridonosP , SalantiG . Graphical tools for network meta‐analysis in STATA. PLoS ONE2013;8(10):e76654.">Chaimani 2013</a>). In view of the difficulty of detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert to duplication of data. </p> </section> <section id="CD005291-sec-0035"> <h4 class="title">Data synthesis</h4> <p>When multiple studies were available for a similar comparison, we used <a href="./references#CD005291-bbs2-0091" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a> software to perform the meta‐analyses, employing the Mantel‐Haenszel method with a fixed‐effect model; otherwise, results from trials that could not be combined were presented in data tables in a narrative format. </p> </section> <section id="CD005291-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned that when sufficient data were available, we would perform subgroup analyses of the following subgroups to determine the potential causes of heterogeneity. </p> <p> <ul id="CD005291-list-0013"> <li> <p>Polar body biopsy</p> </li> <li> <p>Cleavage stage biopsy</p> </li> <li> <p>Blastocyst stage biopsy</p> </li> </ul> </p> <p>If we detected substantial heterogeneity, we would explore it by employing the random‐effects model. We aimed to take any statistical heterogeneity into account when interpreting the results, especially if there was any variation in the direction of effect. </p> <p>We did not pool the results per subgroup for the comparison ‘IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses’, since the stages of biopsy are different. </p> </section> <section id="CD005291-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analyses for the primary outcome. These analyses included consideration of whether the review conclusions would have differed if: </p> <p> <ol id="CD005291-list-0014"> <li> <p>the summary effect measure had been risk ratio rather than odds ratio;</p> </li> <li> <p>eligibility had been restricted to studies with low risk of bias for randomisation and allocation concealment. </p> </li> </ol> </p> </section> <section id="CD005291-sec-0038"> <h4 class="title">Overall quality of the body of evidence: 'Summary of findings' tables</h4> <p>We prepared 'Summary of findings' tables using <a href="./references#CD005291-bbs2-0060" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 15 January 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a> and Cochrane methods. These tables evaluate the overall quality of the body of evidence for the main review outcomes (cumulative live birth, live birth rate after the first embryo transfer, miscarriage rate per woman, ongoing pregnancy rate, and clinical pregnancy rate) for the two main review comparisons (IVF with PGT‐A versus IVF without PGT‐A with use of genome‐wide analyses; and IVF with PGT‐A versus IVF without PGT‐A with use of FISH for genetic analysis). We assessed the quality of the evidence using the GRADE criteria: risk of bias, consistency of effect, imprecision, indirectness, and publication bias. Two review authors (SC and MZ) independently made judgements about evidence quality (high, moderate, low, or very low); in the case of disagreement between review authors, a third review author (EK) was consulted to establish consensus. Judgements were justified, documented, and incorporated into the reporting of results for each outcome. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005291-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005291-sec-0039"></div> <section id="CD005291-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD005291-sec-0041"> <h4 class="title">Results of the search</h4> <p>For this update, we screened 1899 titles and identified 22 articles from searching electronic databases and other resources. From these 22 studies, we included three new studies, nine studies were earlier included. One study was excluded in the previous version of the review, but is included in this updated version (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>).12 articles were excluded because they did not meet the inclusion criteria of the review; the reasons for their exclusion are shown in <a href="./references#CD005291-sec-0133" title="">Characteristics of excluded studies</a>. One of these trials was stopped early due to recruitment problems and is not published (<a href="./references#CD005291-bbs2-0020" title="NCT02265614. PGS Using Microarray in IVF Patients With Repeated Implantation Failure [Preimplantation Genetic Screening (PGS) Using Microarray Technique: Method to Select the Embryo With the Greatest Chance for Successful Implantation During in Vitro Fertilization in Couples With a History of Unsuccessful IVF Attempts]. https://clinicaltrials.gov/ct2/show/NCT02265614 16-10-2014. ">NCT02265614</a>). Ten other studies are ongoing and documented in the <a href="./references#CD005291-sec-0135" title="">Characteristics of ongoing studies</a> section of the review. One study is awaiting classification (see <a href="./references#CD005291-sec-0134" title="">Characteristics of studies awaiting classification</a>). Consequently, we included 13 studies with a total of 2794 participants in the review. Details of the screening and selection process are shown in the PRISMA study flow diagram (<a href="#CD005291-fig-0001">Figure 1</a>). </p> </section> <section id="CD005291-sec-0042"> <h4 class="title">Included studies</h4> <section id="CD005291-sec-0043"> <h5 class="title">Study design and setting</h5> <p>We included a total of 13 studies in this update review, nine studies from the previous version and three new studies. One earlier excluded study was included in this version of the review (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>). This study was previously excluded for the reason that only biochemical pregnancy rates were reported, but it was possible to extract data for one secondary outcome, therefore this study is now included. </p> <p>A couple was offered one treatment cycle in 10 trials, <a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>, and a maximum of three cycles in one trial (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>). In one trial a non‐randomised treatment cycle was offered to participants in the PGT‐A group if in the first treatment cycle all oocytes were aneuploid (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). Eleven participants started a second cycle, 10 of which had ICSI in a second cycle, and PGT‐A was performed for nine of them. Of the nine evaluated participants, six did not have any euploid embryos in this second cycle. The authors kindly provided us data about those outcomes, which permitted an analysis per first treatment cycle (<a href="./references#CD005291-bbs2-0106" title="SermonK . Cochrane review update: preimplantation genetic screening. Cornelisse S 27-02-2019.">Verpoest 2018 [pers comm]</a>). In one trial a couple could participate in the study several times with independent randomisation for each cycle (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). The authors of the <a href="./references#CD005291-bbs2-0101" title="TwiskM , MastenbroekS , vanWelyM , HeinemanMJ , Van der VeenF , ReppingS . Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD005291. [DOI: 10.1002/14651858.CD005291.pub2]">Twisk 2006</a> Cochrane Review provided data for this trial, in which each participant was only included in one treatment group, by personal communication, and we used them again in this update (<a href="./references#CD005291-bbs2-0051" title="DebrockS . Results after the first treatment cycle[personal communication]. Personal communication with the authors of the PGS Cochrane 2011 Unknown.">DeBrock 2010 [pers comm]</a>). </p> <p><a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a> published one paper where two studies are described. In the first study patients with AMA were included, and in the second study patients with RIF could participate. We only used the data for women with RIF in this review. In the study group of participants with AMA, a second IVF treatment cycle was offered to participants before randomisation, therefore no data per started cycle could be extracted. </p> <p>In three trials one embryo was transferred (<a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>); in one trial two embryos were transferred if there were two embryos available (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>); in two trials one or two embryos were transferred according to the policy per centre, participant wishes, and the availability of normal embryos (<a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>); and in one trial up to three embryos were transferred (<a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>). In one trial the number of embryos transferred depended on the age of the woman, namely up to three blastocysts when the woman was between 37 and 39 years old and up to a maximum of six blastocysts if the woman was 40 years of age or older (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>). In one trial a maximum of two to three embryos were transferred before 1 July 2003, and only one embryo after 1 July 2003 in the first IVF attempt in women younger than 36 years (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). In two trials the transfer policy was not described (<a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>). </p> <p>All trials performed fresh embryo transfers, except for one recent trial where a freeze‐all strategy was used (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). Data on cryopreservation and pregnancies originating from frozen‐thawed embryos were available in four trials (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In one of these trials only one embryo transfer was performed in the PGT‐A group and two in the control group, although many more embryos were cryopreserved (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). In this study, one pregnancy was obtained in the PGT‐A group after a mixed transfer of both a non‐biopsied embryo (from a previous IVF cycle) and a biopsied embryo, so no conclusion regarding the origin of the embryo could be made. In this study no pregnancies were obtained in the control group. </p> <p>In all of the included studies, in the control group the morphologically best embryos were transferred, and in the intervention group embryos that were found to be chromosomally normal were transferred. In two studies undetermined embryos with good morphologic features were transferred if no chromosomally normal embryos with good morphologic features were available (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>); in the other studies undetermined embryos were not transferred. Although in one study, one embryo was transferred in which no result was obtained for chromosomes 16 and 18 due to technical difficulties, and one embryo was transferred in which the chromosomal pattern was only evaluated in one nucleus, whilst this study normally removed and investigated two embryos (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). </p> <p>The sample size was based on a power calculation in 10 trials (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). In four trials the calculated number of inclusions was not reached. In one trial the study was ended prematurely because an interim analysis showed such a lower implantation rate for the PGT‐A group that it was considered unethical to continue (<a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>); in one trial the study was ended prematurely because an interim analysis showed futility (<a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>); and a further trial was ended prematurely because the trend was opposite to that required to disprove the null hypothesis and because in the control group many more cryo‐stored blastocysts were accumulating (<a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>). In one trial the study was ended prematurely because an interim analysis showed a very low conditional power of superiority for the primary outcome (<a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>). In one trial the targeted sample size was not reached because of suboptimal recruitment; however, the included sample allowed a 90% power to detect the targeted increase (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In three studies the power calculation was based on embryos instead of women (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). </p> <p>In the <a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a> study, 400 women were randomised, with 200 assigned to the PGT‐A group and 200 to the control group. In the PGT‐A group one woman did not fulfil the inclusion criteria, whilst in the control group 10 women did not fulfil the inclusion criteria, therefore a total of 199 versus 190 women were correctly assigned to the treatment and control group respectively. In 51 women in the treatment group and 49 women in the control group ovum pick‐up was not performed. In the original article these women were excluded from the analysis, but we included these women in an ITT analysis, therefore we included from this article a total of 199 women in the PGT‐A group and 190 women in the control group. </p> <p>In the <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a> study, 95 women were randomised to the PGT‐A group and 105 women were randomised to the control group. In the PGT‐A group eight women did not fulfil the inclusion criteria, whilst in the control group 10 women did not fulfil the inclusion criteria; we excluded these from the meta‐analysis. The authors excluded nine women in the PGT‐A group and 11 women in the control group because of wrong allocation and a spontaneous pregnancy, therefore a total of 87 versus 95 women were correctly assigned to the treatment and the control group respectively. Nine women in the PGT‐A group and 10 women in the control group were wrongly allocated. These women should have been included in an ITT analysis; however, this was not possible because the results of their treatment are unknown to us. The study authors further excluded six women in the PGT‐A group and 18 women in the control group because of insufficient ovarian response, stop further fertility treatment, and spontaneous pregnancy. These women should have been included in an ITT analysis, but this was not possible for the same reason described above. Consequently, from this article we included a total of 72 women in the PGT‐A group and 67 women in the control group. </p> <p>In the <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a> study, four women were excluded from the analysis because no embryo transfer was performed for personal reasons. In the original article these women were excluded from the analysis, but we included these women in an ITT analysis, therefore from this article we included 23 women in the PGT‐A group and 24 women in the control group. </p> <p>In the <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a> study, 52 women were randomised to the PGT‐A group and 52 women to the control group. However, women could be included several times with independent randomisation for each cycle, which introduces a bias since these cycles are not independent. After excluding these cycles, that is when each woman could be included only once, 44 women could be included in the PGT‐A group and 50 women in the control group (<a href="./references#CD005291-bbs2-0051" title="DebrockS . Results after the first treatment cycle[personal communication]. Personal communication with the authors of the PGS Cochrane 2011 Unknown.">DeBrock 2010 [pers comm]</a>). Fifteen women in the PGT‐A group and 28 women in the control group did not receive the intended treatment; we included these women in an ITT analysis, therefore from this study we included 44 women in the PGT‐A group and 50 women in the control group. </p> <p>One study reported only percentages and used transfers and pregnancies as units of analysis, therefore we recalculated the numbers per participant for the various outcomes (<a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>). From this article we included 32 women in the PGT‐A group and 30 women in the control group. </p> </section> <section id="CD005291-sec-0044"> <h5 class="title">Types of participants</h5> <p>PGT‐A was performed for the indication advanced maternal age in seven studies (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>); in good‐prognosis patients in five studies (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>); and for the indication repeated IVF failure in three studies (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). </p> <p>We included seven studies for the indication advanced maternal age. Advanced maternal age was defined as 37 years or higher (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>), 35 years or higher (<a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), 36 to 40 years (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), 35 till 41 years (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>), 38 years or higher (<a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>), and 39 years or higher (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>). Other inclusion criteria in these studies were: normal karyotype of both partners (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>), absence of any type of hereditary condition in the patients or partners personal and family history (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), body mass index (BMI) between 18 and 30 kg/m² (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), need for ICSI with motile sperm (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>), at least two fertilised oocytes one day after ovum pick‐up (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), at least two 6‐cell stage embryos on day 3 (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), at least five 6‐cell stage embryos with no more than 15% fragmentation on day 3 (<a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>), no previous failed IVF cycles (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>), not three or more previous failed IVF cycles (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), no objection to double embryo transfer (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), and at least three embryos of good morphological quality if double embryo transfer was performed, or at least two embryos of good morphological quality if single embryo transfer was performed (<a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>). </p> <p>We included five studies for the indication good‐prognosis patients. Good‐prognosis patients were defined in one trial as patients below 39 years, with normal ovarian reserve, BMI below 30 kg/m², presence of ejaculated sperm, a normal uterus, no more than two previous failed IVF cycles, and at least four embryos containing at least 5 cells with less than 40% fragmentation (<a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>). In another trial, good‐prognosis patients were defined as women below 36 years with the need for ICSI with motile sperm and a normal karyotype of both partners (<a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>). In the third trial, good‐prognosis patients were defined as patients below 38 years, with no objection to single embryo transfer, in their first or second IVF attempt with no cycles cancelled because of poor response. Additional criteria were: no fewer than eight ovarian follicles over 1 cm in diameter at day 8 to 10 of stimulation, at least four embryos with seven or more cells on day 3 of culture, and at least two blastocysts for biopsy on day 5 or 6 (<a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>). In the latest trial, good‐prognosis patients were defined as female age 25 to 40 years undergoing IVF with autologous oocytes with at least two blastocysts of sufficient quality, but the exclusion criteria for this trial included more than two failed IVF‐embryo transfers, more than one miscarriage, or severe male factor (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). </p> <p>We included three studies for the indication repeated IVF failure. In these three studies repeated IVF failure was defined as three or more failed IVF or ICSI attempts with embryos of good morphological quality (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). In one study other inclusion criteria were subfertility with need for assisted reproduction with motile spermatozoa, maternal age less than 37 years, and a normal karyotype in both partners (<a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>). In another study other inclusion criteria were maternal age less than 40 years, fresh embryos in each cycle, and no abnormality in the infertility work‐up (<a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). </p> </section> <section id="CD005291-sec-0045"> <h5 class="title">Types of interventions</h5> <p> <ul id="CD005291-list-0015"> <li> <p>One study compared PGT‐A with biopsy of the first and second polar body with the use of array comparative genomic hybridisation (aCGH) as genome‐wide analysis technique versus no PGT‐A (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). </p> </li> <li> <p>No studies performed PGT‐A with biopsy in cleavage stage with the use of genome‐wide analyses. </p> </li> <li> <p>One study performed PGT‐A with biopsy at the blastocyst stage with the use of next‐generation sequencing (NGS)–based genome‐wide analyses versus no PGT‐A (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). </p> </li> <li> <p>Ten studies compared PGT‐A with cleavage stage biopsies with the use of FISH for the genetic analysis versus no PGT‐A (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). </p> </li> <li> <p>One study compared PGT‐A with biopsy in the blastocyst stage with the use of FISH for the genetic analysis versus no PGT‐A followed by FISH genetic analysis versus no PGT‐A (<a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>). </p> </li> </ul> </p> <p>In the majority of studies the aneuploidy screening was performed by FISH (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). In two studies the aneuploidy screening was performed with the use of genome‐wide analyses (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). In one study PGT‐A was performed with use of aCGH analysis of both polar bodies (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In another study blastocyst trophectoderm biopsy was followed by NGS (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). </p> </section> <section id="CD005291-sec-0046"> <h5 class="title">Types of outcomes</h5> <p>Cumulative live birth rate outcomes could be analysed from two trials (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). The live births were those recorded following embryo transfer, thus including spontaneous pregnancies. In the <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a> study, the primary outcome was live birth per participant within one year from the first follicle aspiration after enrolment in the study. The live births were those recorded following embryo transfer, thus excluding deliveries following coincidental spontaneous pregnancies. The results in this review data analysis were per first treatment cycle; the study authors kindly provided live birth data per first treatment cycle on request (<a href="./references#CD005291-bbs2-0106" title="SermonK . Cochrane review update: preimplantation genetic screening. Cornelisse S 27-02-2019.">Verpoest 2018 [pers comm]</a>). In another trial the results of frozen‐thawed embryos of the first treatment cycle and the spontaneous pregnancies were taken into account (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>). Only cumulative ongoing pregnancy rates per treatment cycle were provided. The authors kindly provided us the cumulative live birth rate per first treatment cycle (<a href="./references#CD005291-bbs2-0072" title="MastenbroekS . Data of the first treatment cycle [personal communication]. Email to: Cornelisse S 19-06-2020.">Mastenbroek 2007 [pers comm]</a>). In this trial two live births were obtained after a frozen‐thawed embryo transfer in the control group, and no pregnancies were obtained in the PGT‐A group (<a href="./references#CD005291-bbs2-0072" title="MastenbroekS . Data of the first treatment cycle [personal communication]. Email to: Cornelisse S 19-06-2020.">Mastenbroek 2007 [pers comm]</a>. </p> <p>The live birth rate after the first embryo transfer per woman was reported in seven trials (<a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). In one trial the live birth rate after the embryo transfer was incomplete since one pregnancy was still ongoing at the time of writing (<a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>), but the author kindly provided us the outcome of this pregnancy (<a href="./references#CD005291-bbs2-0042" title="BlockeelC . Definition of live birth [personal communication]. Personal communication with the authors of the PGS Cochrane 2011 Unknown.">Blockeel 2018 [pers comm]</a>). In one trial the live birth rate was reported per participant, but the authors kindly provided us the outcome of the live birth rate after the first transfer (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>). In one trial live birth rate was not reported, but it was possible to calculate the numbers from the data provided (<a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>). The outcome measure live birth was not defined the same in all studies. Live birth was defined as a live‐born child after 20 weeks of gestation (<a href="./references#CD005291-bbs2-0042" title="BlockeelC . Definition of live birth [personal communication]. Personal communication with the authors of the PGS Cochrane 2011 Unknown.">Blockeel 2018 [pers comm]</a>;<a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>), as a live‐born child after 24 weeks of gestation (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>), as progression of pregnancy past the 24th week of gestation (<a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>), or it was not defined (<a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In the <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a> study, the primary study outcome ongoing pregnancy rate at 20 weeks gestation reflects the live birth rate, as all ongoing pregnancies continued to live birth in this study cohort. </p> <p>Miscarriage data were available for all included studies expect one (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>). Miscarriage data were confirmed to be loss of a clinical pregnancy (not biochemical) in three studies (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In seven studies the miscarriage data were a mixture of biochemical and clinical pregnancy losses (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). In one study miscarriage was not defined (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). We have taken the pragmatic view to include all miscarriage data independent of the used definition, as according to the study authors the majority of the pregnancy losses were from clinical pregnancies. </p> <p>Ongoing pregnancy was reported in five studies (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). A clinical pregnancy was defined as the presence of at least one intrauterine gestational sac on ultrasound exam, <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>, or as fetal heart activity on ultrasound exam. Seven studies reported multiple pregnancy rates (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In nine studies the proportion of women reaching embryo transfer was reported (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). The mean number of embryos per transfer could be calculated in nine studies (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). </p> </section> </section> <section id="CD005291-sec-0047"> <h4 class="title">Excluded studies</h4> <p>We excluded 12 studies. Six of these studies performed PGT‐A with the use of genome‐wide analyses (<a href="./references#CD005291-bbs2-0025" title="YangZ , LiuJ , CollinsGS , SalemSA , LiuX , LyleSS , et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Molecular Cytogenetics2012;5(1):24. [DOI: 10.1186/1755-8166-5-24]">Yang 2012</a>; <a href="./references#CD005291-bbs2-0014" title="FormanEJ , HongKH , FerryKM , TaoX , TaylorD , LevyB , et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertility and Sterility2013;100(1):100-7. [DOI: 10.1016/j.fertnstert.2013.02.056]">Forman 2013</a>; <a href="./references#CD005291-bbs2-0023" title="ScottRT , UphamKM , FormanEJ , HongKH , ScottKL , TaylorD , et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertility and Sterility2013;100(3):697-703. [DOI: 10.1016/j.fertnstert.2013.04.035]">Scott 2013</a>; <a href="./references#CD005291-bbs2-0015" title="FormanEJ , HongKH , FranasiakJM , Scott RT Jr. Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rate. American Journal of Obstetrics and Gynecology2014;210(2):157-160. [DOI: 10.1016/j.ajog.2013.10.016]">Forman 2014</a>; <a href="./references#CD005291-bbs2-0022" title="RubioC , BellverJ , RodrigoL , CastillónG , GuillénA , VidalC , et al. In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study. Fertility and Sterility2017;107(5):1145-1146. [DOI: 10.1016/j.fertnstert.2017.03.011.]">Rubio 2017</a>; <a href="./references#CD005291-bbs2-0021" title="OzgurK , BerkkanogluM , BulutH , YorukGD , CandurmazNN , CoetzeeK . Single best euploid versus single best unknown-ploidy blastocyst frozen embryo transfers: a randomized controlled trial. Journal of Assisted Reproduction and Genetics2019;36(4):629-36. [DOI: 10.1007/s10815-018-01399-1]">Ozgur 2019</a>), and the other six studies performed PGT‐A with the use of FISH for the genetic analysis (<a href="./references#CD005291-bbs2-0016" title="GianaroliL , MagliMC , FerrarettiAP , FiorentineA , GarrisiJ , MunneS . Preimplantation genetic diagnosis increases the preimplantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertility and Sterility1997;68(6):1128-31. ">Gianaroli 1997</a>; <a href="./references#CD005291-bbs2-0017" title="GianaroliL , MagliMC , FerrarettiAP , MunneS . Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertility and Sterility1999;72(5):837-8. ">Gianaroli 1999</a>; <a href="./references#CD005291-bbs2-0024" title="StevensJ , WaleP , SurreyES , SchoolcraftWB . Is aneuploidy screening for patients aged 35 or over beneficial? A prospective randomized trial. Fertility and Sterility2004;82(Suppl 2):249. [DOI: https://doi.org/10.1016/j.fertnstert.2004.07.664]">Stevens 2004</a>; <a href="./references#CD005291-bbs2-0018" title="MersereauJE , PergamentE , ZhangX , MiladMP . Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial. Fertility and Sterility2008;90(4):1287-9. ">Mersereau 2008</a>; <a href="./references#CD005291-bbs2-0019" title="MoayeriM , SaeidiH , ModarresiMH , HashemiM . The effect of preimplantation genetic screening on implantation rate in women over 35 years of age. Cell Journal2016;18(1):13-20. ">Moayeri 2016</a>). </p> <p>Two studies were excluded after retrieving and reading the full text because couples were allocated to the treatment or control group on the basis of their volunteer decision, instead of random allocation (<a href="./references#CD005291-bbs2-0016" title="GianaroliL , MagliMC , FerrarettiAP , FiorentineA , GarrisiJ , MunneS . Preimplantation genetic diagnosis increases the preimplantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertility and Sterility1997;68(6):1128-31. ">Gianaroli 1997</a>; <a href="./references#CD005291-bbs2-0017" title="GianaroliL , MagliMC , FerrarettiAP , MunneS . Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertility and Sterility1999;72(5):837-8. ">Gianaroli 1999</a>). One study was excluded because the trial was stopped early and no data published (<a href="./references#CD005291-bbs2-0020" title="NCT02265614. PGS Using Microarray in IVF Patients With Repeated Implantation Failure [Preimplantation Genetic Screening (PGS) Using Microarray Technique: Method to Select the Embryo With the Greatest Chance for Successful Implantation During in Vitro Fertilization in Couples With a History of Unsuccessful IVF Attempts]. https://clinicaltrials.gov/ct2/show/NCT02265614 16-10-2014. ">NCT02265614</a>). One study, <a href="./references#CD005291-bbs2-0024" title="StevensJ , WaleP , SurreyES , SchoolcraftWB . Is aneuploidy screening for patients aged 35 or over beneficial? A prospective randomized trial. Fertility and Sterility2004;82(Suppl 2):249. [DOI: https://doi.org/10.1016/j.fertnstert.2004.07.664]">Stevens 2004</a>, was excluded because the participants included in this study were also included in another, larger study (<a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>). <a href="./references#CD005291-bbs2-0019" title="MoayeriM , SaeidiH , ModarresiMH , HashemiM . The effect of preimplantation genetic screening on implantation rate in women over 35 years of age. Cell Journal2016;18(1):13-20. ">Moayeri 2016</a> was excluded because the authors only reported on biochemical pregnancies, and number of participants reaching embryo transfer was not reported. We excluded other studies due to inappropriate design or reporting of the study that did not allow for a fair evaluation of the effect of PGT‐A on IVF treatment outcomes, such as the use of single embryo transfer (SET) in the PGT‐A group versus double embryo transfer (DET) in the control group, <a href="./references#CD005291-bbs2-0014" title="FormanEJ , HongKH , FerryKM , TaoX , TaylorD , LevyB , et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertility and Sterility2013;100(1):100-7. [DOI: 10.1016/j.fertnstert.2013.02.056]">Forman 2013</a>; <a href="./references#CD005291-bbs2-0015" title="FormanEJ , HongKH , FranasiakJM , Scott RT Jr. Obstetrical and neonatal outcomes from the BEST Trial: single embryo transfer with aneuploidy screening improves outcomes after in vitro fertilization without compromising delivery rate. American Journal of Obstetrics and Gynecology2014;210(2):157-160. [DOI: 10.1016/j.ajog.2013.10.016]">Forman 2014</a>, and only reporting on women that had an embryo transfer, <a href="./references#CD005291-bbs2-0025" title="YangZ , LiuJ , CollinsGS , SalemSA , LiuX , LyleSS , et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Molecular Cytogenetics2012;5(1):24. [DOI: 10.1186/1755-8166-5-24]">Yang 2012</a>; <a href="./references#CD005291-bbs2-0023" title="ScottRT , UphamKM , FormanEJ , HongKH , ScottKL , TaylorD , et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertility and Sterility2013;100(3):697-703. [DOI: 10.1016/j.fertnstert.2013.04.035]">Scott 2013</a>. In IVF with PGT‐A, compared to IVF without PGT‐A, a relatively large group of women will not have an embryo transfer, as all embryos are considered aneuploid or unsuitable for transfer. If a study only includes women with an embryo transfer or only reports outcomes per embryo transfer, then the study favours PGT‐A by design by leaving these women that do not get pregnant (as they do not have an embryo transfer) out of the equation. These studies do not permit the drawing of any conclusion on the effect of PGT‐A on IVF effectiveness, where treatment outcomes should be calculated per woman (including all women going for treatment) or per started treatment cycle (including all started treatments). One study was excluded because outcome measures were reported as percentages without mentioning the unit of analysis, and it was not possible to calculate the exact numbers (<a href="./references#CD005291-bbs2-0018" title="MersereauJE , PergamentE , ZhangX , MiladMP . Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial. Fertility and Sterility2008;90(4):1287-9. ">Mersereau 2008</a>). In two other studies multiple ovum pickups were allowed to collect oocytes before a transfer was attempted, and it was not possible to calculate the exact numbers per first ovum pick‐up (<a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0022" title="RubioC , BellverJ , RodrigoL , CastillónG , GuillénA , VidalC , et al. In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study. Fertility and Sterility2017;107(5):1145-1146. [DOI: 10.1016/j.fertnstert.2017.03.011.]">Rubio 2017</a>). Multiple ovum‐pickups per woman before PGT‐A is performed hampers a fair evaluation of the effect of PGT‐A on IVF treatment outcomes, as such an artificial increase of oocyte number can be expected to benefit the PGT‐A arm more than the control arm, especially when reporting per first transfer only, and it was not possible to correct for this different strategy. In the <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a> study, data from the AMA group were excluded for this reason. The authors of <a href="./references#CD005291-bbs2-0021" title="OzgurK , BerkkanogluM , BulutH , YorukGD , CandurmazNN , CoetzeeK . Single best euploid versus single best unknown-ploidy blastocyst frozen embryo transfers: a randomized controlled trial. Journal of Assisted Reproduction and Genetics2019;36(4):629-36. [DOI: 10.1007/s10815-018-01399-1]">Ozgur 2019</a> performed blastocyst stage biopsy in only the best morphologically scoring embryo in case a participant was randomised to the PGT‐A group. Euploid embryos were transferred when available, otherwise a non‐biopsied embryo was chosen for transfer. Consequently, the right unit of analysis (e.g. per woman or per ovum pick‐up) could not be used for evaluating PGT‐A effectiveness. </p> </section> </section> <section id="CD005291-sec-0048"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias in the included studies is summarised in <a href="#CD005291-fig-0002">Figure 2</a> and <a href="#CD005291-fig-0003">Figure 3</a>. </p> <section id="CD005291-sec-0049"> <h4 class="title">Allocation</h4> <section id="CD005291-sec-0050"> <h5 class="title">Sequence generation</h5> <p>As shown in <a href="#CD005291-fig-0002">Figure 2</a> and <a href="#CD005291-fig-0003">Figure 3</a>, seven studies reported adequate methods for random sequence generation and were therefore rated as at low risk of bias for sequence generation (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). The other six studies did not describe the method used and were rated as at unclear risk of bias for this domain. </p> </section> <section id="CD005291-sec-0051"> <h5 class="title">Allocation concealment</h5> <p>Four studies described adequate methods for allocation concealment (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). The remaining nine studies did not describe methods of allocation concealment and were scored as at unclear risk of bias for this domain. </p> </section> </section> <section id="CD005291-sec-0052"> <h4 class="title">Blinding</h4> <section id="CD005291-sec-0053"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p>In three studies participants and clinicians were blinded (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). Participants and clinicians involved in the study were blinded until after embryo transfer, <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>, or study completion, <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>. </p> <p>In six studies participating women and personnel were not blinded (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). Three trials did not mention whether participants and treatment providers were blind to assignment status (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>). We assessed these nine studies as being at high risk of performance bias. None of the included studies blinded the personnel performing PGT‐A, but this would have been impossible. </p> </section> <section id="CD005291-sec-0054"> <h5 class="title">Blinding of outcome assessors (detection bias)</h5> <p>We judged all 13 studies to be at low risk of detection bias because the outcomes (cumulative live birth, live birth, miscarriage, ongoing pregnancy, and clinical pregnancy) are objective and therefore cannot be influenced by knowledge of the intervention. One study described that blinding for outcome assessors was performed (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>). In the remaining studies outcome assessors were not blinded, however we still deemed these studies as having a low risk of bias due to the reason described above. </p> </section> </section> <section id="CD005291-sec-0055"> <h4 class="title">Incomplete outcome data</h4> <p>In seven trials there were dropouts in both the intervention and the control group (respectively 52/200 and 77/206 and 13/120 and 14/95 and 15/52 and 8/205 and 56/330 in the intervention group and 59/200 and 71/202 and 13/120 and 28/105 and 28/52 and 7/191 and 18/331 in the control group) (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). Reasons for cancelling the intended treatment cycle were insufficient ovarian response (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>), no oocytes at ovum pick‐up (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), no fertilisation (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), fewer than two fertilised oocytes available (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), fewer than two embryos with at least six cells available on day 3 (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), no embryo available for biopsy (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), no euploid embryos available for transfer, thaw failure, protocol deviation (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>), cancer cyst detected (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>), no technical support for genetic analysis (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), other medical reasons (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), inability to manage the treatment burden (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>), stop further fertility treatment (<a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>), spontaneous pregnancy (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), not finished at the end of follow‐up (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>), participant withdrew (<a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>), and other reasons (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>). Dropouts were included in an ITT analysis in three trials (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>), but they were not included in an ITT analysis in the other trials (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). The remaining trials did not mention dropouts. In one study, four women declined embryo transfer for reasons not related to the study, two in the PGT‐A treatment group and two in the control group; these women were not included in an ITT analysis (<a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>). Dr Debrock kindly provided the writers of the previous version of this review the information about the dropout cycles so it could be included in an ITT analysis. </p> </section> <section id="CD005291-sec-0056"> <h4 class="title">Selective reporting</h4> <p>There was no evidence of selective reporting. We considered all studies to be at low risk of reporting bias because they reported and published all outcomes they had set out to investigate. This was confirmed on communication with authors and by referencing against information in online trials registers if available. </p> </section> <section id="CD005291-sec-0057"> <h4 class="title">Other potential sources of bias</h4> <p>We found no potential sources of within‐study bias in 11 studies and assessed these studies as having a low risk of other bias (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0009" title="SchoolcraftWB , Katz-JaffeMG , StevensJ , RawlinsM , MunneS . Preimplantation aneuploidy testing for infertile patients of advanced maternal age. Fertility and Sterility2009;92(1):157-62. ">Schoolcraft 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). </p> <p>We assessed two studies as having a high risk of within‐study bias (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>). This was due to the difference in day of embryo transfer between study arms (day 5 for intervention and day 3 for control (<a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>); or day 3 or 5 for the control group based on physician preference (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>)). This difference in maturity of the embryo could have had an impact on the likelihood of an ongoing pregnancy. </p> </section> </section> <section id="CD005291-sec-0058"> <h3 class="title" id="CD005291-sec-0058">Effects of interventions</h3> <p>See: <a href="./full#CD005291-tbl-0001"><b>Summary of findings 1</b> Preimplantation genetic testing for aneuploidies with the use genome‐wide analyses in in vitro fertilisation</a>; <a href="./full#CD005291-tbl-0002"><b>Summary of findings 2</b> Preimplantation genetic testing for aneuploidies with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis in in vitro fertilisation</a> </p> <p><b>See:</b> Preimplantation genetic testing for aneuploidies with the use genome‐wide analyses in in vitro fertilisation (<a href="./full#CD005291-tbl-0001">summary of findings Table 1</a>) and Preimplantation genetic testing for aneuploidies with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis in in vitro fertilisation (<a href="./full#CD005291-tbl-0002">summary of findings Table 2</a>). </p> <section id="CD005291-sec-0059"> <h4 class="title">(1) IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses</h4> <p>Two studies undertook this comparison (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>), with a total of 1057 participants. </p> <section id="CD005291-sec-0060"> <h5 class="title">Primary outcomes</h5> <section id="CD005291-sec-0061"> <h6 class="title">1.1 Cumulative live birth rate after the first treatment cycle per woman randomised</h6> <section id="CD005291-sec-0062"> <p><b>Polar body biopsy</b></p> <p>Only one study provided cumulative live birth data (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). There were 50 events reported in the women randomised to the PGT‐A arm and 45 events in the 396 women randomised to the control arm. It is unclear whether there is any difference in rate of cumulative live birth per woman between the groups (odds ratio (OR) 1.05, 95% confidence interval (CI) 0.66 to 1.66, 1 RCT, N = 396, low‐quality evidence) (<a href="./references#CD005291-fig-0009" title="">Analysis 1.1</a>, <a href="#CD005291-fig-0004">Figure 4</a>). The evidence suggests that if the rate of cumulative live birth in the control groups is 24%, the rate with the use of PGT‐A with genome wide‐analysis would be between 17% and 34%. </p> <div class="figure" id="CD005291-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.1 Cumulative live birth rate after the first treatment cycle, per woman randomised." data-id="CD005291-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.1 Cumulative live birth rate after the first treatment cycle, per woman randomised. </p> </div> </div> </div> <p>We did not perform a sensitivity analysis restricted to studies at low risk of selection bias as only one included study was at low risk of selection bias. A sensitivity analysis on the effect measured by risk ratio did not influence this finding substantially. </p> </section> <section id="CD005291-sec-0063"> <p><b>Blastocyst stage biopsy</b></p> <p>No data were provided for this outcome.</p> </section> </section> </section> <section id="CD005291-sec-0064"> <h5 class="title">Secondary outcomes</h5> <section id="CD005291-sec-0065"> <h6 class="title">1.2 Live birth rate per first embryo transfer per woman randomised</h6> <p>Two trials involving a total of 1057 women reported on live birth rate after the first embryo transfer (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). We divided the PGT‐A performed with the use of genome‐wide analyses into subgroups of stage of biopsy. </p> <section id="CD005291-sec-0066"> <p><b>Polar body biopsy</b></p> <p>One trial performed biopsy on polar bodies of the embryo. There were 44 events reported in the women randomised to the PGT‐A arm and 38 events in the 396 women randomised to the control arm. It is unclear whether there is any difference in rate of live birth after the first embryo transfer per woman (OR 1.10, 95% CI 0.68 to 1.79, 1 RCT, N = 396, low‐quality evidence) (<a href="./references#CD005291-fig-0010" title="">Analysis 1.2</a>, <a href="#CD005291-fig-0005">Figure 5</a>). The evidence suggests that if the live birth rate after the first embryo transfer in the control groups is 20%, the rate with the use of PGT‐A with the use of genome‐wide analyses would be between 14% and 31%. </p> <div class="figure" id="CD005291-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.2 live birth rate after the first embryo transfer per woman randomised." data-id="CD005291-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.2 live birth rate after the first embryo transfer per woman randomised. </p> </div> </div> </div> </section> <section id="CD005291-sec-0067"> <p><b>Blastocyst stage biopsy</b></p> <p>One trial performed biopsy in the blastocyst stage of the embryo. There were 138 events reported in the women randomised to the PGT‐A arm and 144 events in the 661 women randomised to the control arm (OR 0.93, 95% CI 0.69 to 1.27, 1 RCT, N = 661, low‐quality evidence) (<a href="./references#CD005291-fig-0010" title="">Analysis 1.2</a>, <a href="#CD005291-fig-0005">Figure 5</a>), indicating that we are uncertain about the effectiveness of the intervention. Translated into absolute risks, this means that for a woman with a 44% chance of achieving a live birth after the first embryo transfer without the performance of PGT‐A, the chance of a live birth after the first embryo transfer with PGT‐A with the use of genome‐wide analyses would be between 35% and 50%. </p> </section> </section> <section id="CD005291-sec-0068"> <h6 class="title">1.3 Miscarriage rate per woman randomised</h6> <p>One study defined miscarriage data as loss of clinical pregnancy (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), whilst the other study did not define miscarriage (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). </p> <section id="CD005291-sec-0069"> <p><b>Polar body biopsy</b></p> <p>One trial performed biopsy on polar bodies of the embryo (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). The evidence suggests that PGT‐A performed with the use of genome‐wide analyses may decrease miscarriage rate compared to an IVF treatment without PGT‐A (OR 0.45, 95% CI 0.23 to 0.88, 1 RCT, N = 396, low‐quality evidence) (<a href="./references#CD005291-fig-0011" title="">Analysis 1.3</a>, <a href="#CD005291-fig-0006">Figure 6</a>). The evidence suggests that if the miscarriage rate without the addition of PGT‐A is 14%, the rate associated with PGT‐A with the use of genome‐wide analyses would be between 4% and 13%. </p> <div class="figure" id="CD005291-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 IVF without PGT‐A versus IVF with PGT‐A with the use of genome‐wide analyses, outcome: 1.3 Miscarriage rate per woman randomised." data-id="CD005291-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 IVF without PGT‐A versus IVF with PGT‐A with the use of genome‐wide analyses, outcome: 1.3 Miscarriage rate per woman randomised. </p> </div> </div> </div> </section> <section id="CD005291-sec-0070"> <p><b>Blastocyst stage biopsy</b></p> <p>One trial performed biopsy in the blastocyst stage of the embryo (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). We are uncertain of the effect of PGT‐A performed with the use of genome‐wide analyses on the miscarriage rate compared to IVF treatment without PGT‐A (OR 0.89, 95% CI 0.52 to 1.54, 1 RCT, N = 661, low‐quality evidence) (<a href="./references#CD005291-fig-0011" title="">Analysis 1.3</a>, <a href="#CD005291-fig-0006">Figure 6</a>). The evidence suggests that if the miscarriage rate without the addition of PGT‐A is 8.2%, the rate associated with PGT‐A with the use of genome‐wide analyses would be between 4% and 12%. </p> </section> </section> <section id="CD005291-sec-0071"> <h6 class="title">1.4 Miscarriage rate per pregnancy</h6> <section id="CD005291-sec-0072"> <p><b>Polar body biopsy</b></p> <p>When miscarriage rate is expressed per clinical pregnancy (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>), there also may be reduction in the miscarriage rate in the PGT‐A group (OR 0.47, 95% CI 0.22 to 1.00, 1 RCT, N = 136) (<a href="./references#CD005291-fig-0012" title="">Analysis 1.4</a>). </p> </section> <section id="CD005291-sec-0073"> <p><b>Blastocyst stage biopsy</b></p> <p>No data were provided for this outcome.</p> </section> </section> <section id="CD005291-sec-0074"> <h6 class="title">Ongoing pregnancy rate per woman randomised</h6> <p>No data were provided for this outcome.</p> </section> <section id="CD005291-sec-0075"> <h6 class="title">1.5 Clinical pregnancy per woman randomised</h6> <section id="CD005291-sec-0076"> <p><b>Polar body biopsy</b></p> <p>Only one study reported this outcome (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). There were 63 clinical pregnancies in the 205 women randomised to the intervention group, and 70 pregnancies in the 191 women randomised to the control group. It is unclear whether there is any difference between interventions in clinical pregnancy rates (OR 0.77, 95% CI 0.50 to 1.16, 1 RCT, N = 396, low‐quality evidence) (<a href="./references#CD005291-fig-0013" title="">Analysis 1.5</a>). </p> </section> <section id="CD005291-sec-0077"> <p><b>Blastocyst stage biopsy</b></p> <p>No data were provided for this outcome.</p> </section> </section> <section id="CD005291-sec-0078"> <h6 class="title">1.6 Multiple pregnancy per woman randomised</h6> <section id="CD005291-sec-0079"> <p><b>Polar body biopsy</b></p> <p>One study reported this outcome (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). It is uncertain whether PGT‐A with the use of genome‐wide analyses for embryo selection influences multiple pregnancy rates (OR 0.53, 95% CI 0.20 to 1.37, 1 RCT, N = 396) (<a href="./references#CD005291-fig-0014" title="">Analysis 1.6</a>). </p> </section> <section id="CD005291-sec-0080"> <p><b>Blastocyst stage biopsy</b></p> <p>No data were provided for this outcome.</p> </section> </section> <section id="CD005291-sec-0081"> <h6 class="title">1.7 Multiple pregnancy per live birth</h6> <section id="CD005291-sec-0082"> <p><b>Polar body biopsy</b></p> <p>It is also uncertain if there is a difference between groups in multiple pregnancy rate per live birth (OR 0.45, 95% CI 0.16 to 1.26, 1 RCT, N = 95) (<a href="./references#CD005291-fig-0015" title="">Analysis 1.7</a>). </p> </section> <section id="CD005291-sec-0083"> <p><b>Blastocyst stage biopsy</b></p> <p>No data were provided for this outcome.</p> </section> </section> <section id="CD005291-sec-0084"> <h6 class="title">1.8 Proportion of women reaching embryo transfer</h6> <p>In two studies a total of 423 participants reached an embryo transfer in the PGT‐A group and 484 participants reached an embryo transfer in the control group (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>; <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). </p> <section id="CD005291-sec-0085"> <p><b>Polar body biopsy</b></p> <p>One trial performed biopsy on polar bodies (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). The evidence suggests that PGT‐A performed with the use of genome‐wide analyses decreases the proportion of women reaching an embryo transfer (OR 0.31, 95% CI 0.18 to 0.54, 1 RCT, N = 396) (<a href="./references#CD005291-fig-0016" title="">Analysis 1.8</a>). </p> </section> <section id="CD005291-sec-0086"> <p><b>Blastocyst stage biopsy</b></p> <p>One trial performed biopsy in the blastocyst stage of the embryo (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). The evidence suggests that PGT‐A performed with the use of genome‐wide analyses decreases the proportion of women reaching an embryo transfer (OR 0.28, 95% CI 0.16 to 0.49, 1 RCT, N = 661) (<a href="./references#CD005291-fig-0016" title="">Analysis 1.8</a>). </p> </section> </section> <section id="CD005291-sec-0087"> <h6 class="title">1.9 Mean number of embryos per transfer</h6> <section id="CD005291-sec-0088"> <p><b>Polar body biopsy</b></p> <p>In the <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a> study a single embryo transfer or double transfer was performed subject to availability of (euploid) embryos, that is if there was only one embryo euploid tested, a single embryo transfer was performed (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In the PGT‐A group 177 embryos were transferred with a mean number of 1.4 embryos per transfer. In the control group 249 embryos were transferred with a mean number of 1.8 embryo per transfer. The evidence suggests that PGT‐A with the use of genome‐wide analyses for embryo selection decreases the number of embryos available for transfer, but this finding is unclear as the evidence is of low quality (mean difference (MD) −0.40, 95% CI −0.49 to −0.31, 1 RCT, N = 426) (<a href="./references#CD005291-fig-0017" title="">Analysis 1.9</a>). </p> </section> <section id="CD005291-sec-0089"> <p><b>Blastocyst stage biopsy</b></p> <p>In the study of <a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>, the standard care was a single embryo transfer, in the control group and the intervention group. </p> </section> </section> </section> </section> <section id="CD005291-sec-0090"> <h4 class="title">(2) IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis</h4> <section id="CD005291-sec-0091"> <h5 class="title">Primary outcomes</h5> <section id="CD005291-sec-0092"> <h6 class="title">2.1 Cumulative live birth rate per woman</h6> <p>One study provided cumulative live birth rate data (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>), with a total of 408 participants. It is uncertain whether there is any difference between the group with addition of PGT‐A and the control group in rate of cumulative live birth (OR 0.59, 95% CI 0.35 to 1.01, 1 RCT, N = 408, low‐quality evidence) (<a href="./references#CD005291-fig-0018" title="">Analysis 2.1</a>, <a href="#CD005291-fig-0007">Figure 7</a>). The evidence suggests that for the observed average cumulative live birth rate per woman of 29% in the control group, the chance of live birth following the results of one IVF treatment cycle with PGT‐A is between 12% and 29%. In <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a> PGT‐A was offered to women who were randomly assigned to undergo three cycles of IVF, with embryo selection based on either PGT‐A or conventional embryo selection. For the outcome cumulative live birth rate only the cryopreserved embryos from the first IVF cycle were taken into account. </p> <div class="figure" id="CD005291-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.1 Cumulative live birth rate after the first treatment cycle, per woman randomised." data-id="CD005291-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.1 Cumulative live birth rate after the first treatment cycle, per woman randomised. </p> </div> </div> </div> <p>We did not perform a sensitivity analysis restricted to studies at low risk of selection bias as only one included study was at low risk of selection bias. </p> </section> </section> <section id="CD005291-sec-0093"> <h5 class="title">Secondary outcomes</h5> <section id="CD005291-sec-0094"> <h6 class="title">2.2 Live birth rate per first embryo transfer per woman randomised</h6> <p>All 10 trials for this comparison provided data on live birth after the first embryo transfer. We found that the intervention, PGT‐A with the use of FISH for the genetic analysis, resulted in fewer live births than in the control group (OR 0.62, 95% CI 0.43 to 0.91, 10 RCTs, N = 1680, I² = 54%, moderate‐quality evidence) (<a href="./references#CD005291-fig-0019" title="">Analysis 2.2</a>, <a href="#CD005291-fig-0008">Figure 8</a>). The evidence suggests that for the observed average live birth rate after the first embryo transfer per woman of 31% in the control group, the chance of live birth after the first embryo transfer with PGT‐A is between 16% and 29%. </p> <div class="figure" id="CD005291-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.2 live birth rate after the first embryo transfer per woman randomised." data-id="CD005291-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-08.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.2 live birth rate after the first embryo transfer per woman randomised. </p> </div> </div> </div> <p>We divided the PGT‐A performed with use of FISH into subgroups: one trial performed biopsy on blastocyst stage, and nine trials performed biopsy in cleavage stage of embryo development. There may be little or no difference between the subgroups (P = 0.28). The OR was 0.40 (95% CI 0.18 to 0.90, 1 RCT, N = 101) for PGT‐A with blastocyst stage biopsy and 0.66 (95% CI 0.45 to 0.98, 9 RCTs, N = 1579) for PGT‐A with cleavage stage biopsy (<a href="./references#CD005291-fig-0019" title="">Analysis 2.2</a>, <a href="#CD005291-fig-0008">Figure 8</a>). </p> </section> <section id="CD005291-sec-0095"> <h6 class="title">2.3 Miscarriage rate per woman randomised</h6> <p>All 10 studies provided data on miscarriage. Of 855 women randomised to the intervention arm, 92 experienced a miscarriage, whereas of 825 women randomised to the control arm, 87 experienced a miscarriage. There is probably little or no difference in miscarriage rate between PGT‐A and the control group (OR 1.03, 95% CI 0.75 to 1.41, 10 RCTs, N = 1680, I² = 16%, moderate‐quality evidence) (<a href="./references#CD005291-fig-0020" title="">Analysis 2.3</a>). </p> </section> <section id="CD005291-sec-0096"> <h6 class="title">2.4 Miscarriage rate per clinical pregnancy</h6> <p>When miscarriage rate is expressed per clinical pregnancy (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>), there may be a reduction in miscarriage rate in the control group (OR 1.77, 95% CI 1.10 to 2.86, 5 RCTs, N = 288, I² = 45%, moderate‐quality evidence) (<a href="./references#CD005291-fig-0021" title="">Analysis 2.4</a>). </p> </section> <section id="CD005291-sec-0097"> <h6 class="title">2.5 Ongoing pregnancy rate per woman randomised</h6> <p>Four studies provided data on ongoing pregnancy rate (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). The intervention, PGT‐A with the use of FISH for the genetic analysis, reduces ongoing pregnancies (OR 0.68, 95% CI 0.51 to 0.90, 5 RCTs, N = 1121, I² = 60%, low‐quality evidence) (<a href="./references#CD005291-fig-0022" title="">Analysis 2.5</a>). </p> </section> <section id="CD005291-sec-0098"> <h6 class="title">2.6 Clinical pregnancy rate per woman randomised</h6> <p>Five studies provided clinical pregnancy data (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>). There were 131 clinical pregnancies in the 576 women randomised to the PGT‐A arm and 185 clinical pregnancies in the 555 women randomised to the control arm. The intervention, PGT‐A with the use of FISH for the genetic analysis, reduces clinical pregnancies (OR 0.60, 95% CI 0.45 to 0.81, 5 RCTs, N = 1131, I² = 0%, moderate‐quality evidence) (<a href="./references#CD005291-fig-0023" title="">Analysis 2.6</a>). </p> </section> <section id="CD005291-sec-0099"> <h6 class="title">2.7 Multiple pregnancy rate per woman randomised</h6> <p>Six studies provided multiple pregnancy data (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). There were 20 multiple pregnancies in the 673 women randomised to the PGT‐A arm and 29 multiple pregnancies in the 658 women randomised to the control arm. Due to the wide confidence interval, it is unclear whether there is a difference in the multiple pregnancy rate per woman between the two groups (OR 0.66, 95% CI 0.37 to 1.17, 6 RCTs, N = 1331, I² = 0%) (<a href="./references#CD005291-fig-0024" title="">Analysis 2.7</a>). </p> </section> <section id="CD005291-sec-0100"> <h6 class="title">2.8 Multiple pregnancy rate per live birth</h6> <p>Six studies provided multiple pregnancy rates per live birth (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0011" title="StaessenC , VerpoestW , DonosoP , HaentjensP , Van der ElstJ , LiebaersI , et al. Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Human Reproduction2008;23(12):2818-25. ">Staessen 2008</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). There were 20 multiple pregnancies amongst the 164 live births to the PGT‐A arm and 29 multiple pregnancies amongst the 200 live births to the control arm. Due to the wide confidence interval, it is unclear whether there is difference in the multiple pregnancy rate per live birth between the two groups (OR 0.97, 95% CI 0.51 to 1.82, 6 RCTs, N = 364, I² = 0%) (<a href="./references#CD005291-fig-0025" title="">Analysis 2.8</a>). </p> </section> <section id="CD005291-sec-0101"> <h6 class="title">2.9 Proportion of women reaching embryo transfer</h6> <p>Nine studies provided data on the proportion of women reaching embryo transfer (<a href="./references#CD005291-bbs2-0013" title="WerlinL , RodiI , DeCherneyA , MarelloE , HillD , MunnéS . Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technology. Fertility and Sterility2003;80(2):467-8. [DOI: 10.1016/S0015-0282(03)00605-8]">Werlin 2003</a>; <a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0004" title="JansenRP , BowmanMC , De boerKA , LeighDA , LiebermanDB , McArthurSJ . What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Human Reproduction2008;23(7):1476-8. ">Jansen 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). There were 508 women in the PGT‐A arm and 532 women in the control group reaching an embryo transfer. The proportion of woman reaching embryo transfer probably decreases with the addition of PGT‐A with the use of FISH for the genetic analysis to an IVF treatment (OR 0.54, 95% CI 0.40 to 0.74, 9 RCTs, N = 1286, I<sup>2</sup> = 48%) (<a href="./references#CD005291-fig-0026" title="">Analysis 2.9</a>). </p> </section> <section id="CD005291-sec-0102"> <h6 class="title">2.10 Mean number of embryos per transfer</h6> <p>Seven studies provided data on the mean number of embryos transferred per transfer (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>; <a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0001" title="BlockeelC , SchutyserV , De VosA , VerpoestW , De VosM , StaessenC , et al. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reproductive Biomedicine Online2008;17(6):848-54. ">Blockeel 2008</a>; <a href="./references#CD005291-bbs2-0003" title="HardarsonT , HansonC , LundinK , HillensjoT , NilssonL , StevicJ , et al. Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Human Reproduction2008;23(12):2806-12. ">Hardarson 2008</a>; <a href="./references#CD005291-bbs2-0006" title='MeyerLR , KlipsteinS , HazlettWD , NastaT , ManganP , KarandeVC . A prospective randomized controlled trial of preimplantation genetic screening in the "good prognosis" patient. Fertility and Sterility2009;91(5):1731-8. '>Meyer 2009</a>; <a href="./references#CD005291-bbs2-0002" title="DebrockS , MelotteC , SpiessensC , PeeraerK , VannesteE , MeeuwisL , et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertility and Sterility2010;93(2):364-73. ">Debrock 2010</a>; <a href="./references#CD005291-bbs2-0008" title="RubioC , BellverJ , RodrigoL , BoschE , MercaderA , VidalC , et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertility and sterility2013;99(5):1400-7. [PMID: 23260857]">Rubio 2013</a>). The mean number of embryos transferred per transfer was decreased in the intervention group, PGT‐A with the use of FISH for the genetic analysis (MD −0.23, 95% CI −0.30 to −0.16, 7 RCTs, I² = 81%) (<a href="./references#CD005291-fig-0027" title="">Analysis 2.10</a>). There was statistical heterogeneity, with I² = 81%. This could be explained in part by the fact that the maximum embryos for transfer was much higher in one study, namely up to six if a woman was 40 years or older (<a href="./references#CD005291-bbs2-0010" title="StaessenC , PlatteauP , Van AsscheE , MichielsA , TournayeH , CamusM , et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomised controlled trial. Human Reproduction2004;19(12):2849-58. ">Staessen 2004</a>), as compared to the other studies, where the maximum of embryos for transfer was two or three. However, if this study was excluded from the analysis, the I² was still high, namely 69%. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005291-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005291-sec-0103"></div> <section id="CD005291-sec-0104"> <h3 class="title" id="CD005291-sec-0104">Summary of main results</h3> <p>This review compared the effectiveness and safety of PGT‐A in an IVF treatment. We found two trials that compared the addition of PGT‐A with the use of genome‐wide analyses with an IVF treatment control group, and 10 trials that compared the addition of PGT‐A by FISH with an IVF treatment control group. The aim of the comparisons was to assess the potential advantages of selecting embryos by PGT‐A to increase live birth rates and prevent miscarriages. </p> <section id="CD005291-sec-0105"> <h4 class="title">IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses</h4> <p>All findings for this comparison were uncertain because of the low quality of the evidence due to the limited number of studies. It is unclear whether there is any difference between the addition of PGT‐A by genome‐wide analyses in an IVF treatment versus morphology embryo screening in terms of cumulative live birth or live birth rate after the first embryo transfer. PGT‐A with polar body biopsy may decrease miscarriage rate, but it is uncertain if PGT‐A reduces miscarriage rates with blastocyst stage biopsy. It is unclear whether there is any difference in clinical pregnancy rates. </p> <p>There is insufficient good‐quality evidence of a difference in cumulative live birth rate, live birth rate after the first embryo transfer, or miscarriage rate to choose between an IVF treatment with or without PGT‐A performed by genome‐wide analyses. No data were available on ongoing pregnancy rates. The effect of PGT‐A on clinical pregnancy rate is uncertain. </p> </section> <section id="CD005291-sec-0106"> <h4 class="title">IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis</h4> <p>We are uncertain if the addition of PGT‐A with the use of FISH for the genetic analysis leads to a higher cumulative live birth rate. The addition of PGT‐A probably reduces live birth rate after the first embryo transfer; may reduce ongoing pregnancy; and probably reduces clinical pregnancy rate. There is probably little or no difference in miscarriage between the intervention and the control group. The currently available evidence does not support the routine use of PGT‐A with the use of FISH for the genetic analysis. </p> </section> </section> <section id="CD005291-sec-0107"> <h3 class="title" id="CD005291-sec-0107">Overall completeness and applicability of evidence</h3> <p>The comparisons of PGT‐A with the use of genome‐wide analyses and PGT‐A with the use of FISH for the genetic analysis included 1057 and 1680 women, respectively. </p> <p>In the comparison ‘IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses’, a trophectoderm biopsy in blastocyst stage of the embryo development was performed in one study (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>), whilst analysis of the first and second polar bodies of the fertilised oocytes was performed in the other study (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). </p> <p>It is important to mention that the blastocyst biopsy or trophectoderm biopsy is at present the most widely used technique (<a href="./references#CD005291-bbs2-0096" title="SermonK , CapalboA , CohenJ , CoonenE , De RyckeM , De VosA , et al. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Molecular Human Reproduction2016;22(8):845-57. [DOI: 10.1093/molehr/gaw034 ] [PMID: 27256483]">Sermon 2016</a>; <a href="./references#CD005291-bbs2-0050" title="De RyckeM , GoossensV , KokkaliG , Meijer-HoogeveenM , CoonenE , MoutouC . ESHRE PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. Human Reproduction2017;32:1974-94.">De Rycke 2017</a>). </p> <p>The outcome miscarriage in the comparison ‘IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses’ suggests that the miscarriage rate is probably reduced with the use of PGT‐A in the subgroup with polar body biopsy. In this subgroup, only women "with advanced maternal age", aged 36 to 40 years, were included (<a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). In the subgroup with blastocyst stage biopsy, women were aged 25 to 40 years (<a href="./references#CD005291-bbs2-0007" title="MunnéS , KaplanB , FrattarelliJL , ChildT , NakhudaG , ShammaFN , et al, on behalf of the STAR study group. Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial. Fertility and Sterility December 2019;112(6):1071-79. [DOI: 10.1016/j.fertnstert.2019.07.1346]">Munné 2019</a>). In this last study a post hoc analysis of overall pregnancy outcomes in women aged 35 to 40 years demonstrated no significant difference in the miscarriage rate. </p> <p>There was heterogeneity between the two trials included in the comparison ‘IVF with PGT‐A versus IVF without PGT‐A by genome‐wide analyses’. The included participants had different indications for PGT‐A; the timing of the biopsy in embryo development was dissimilar; and the embryo transfer policy ‘fresh and or only frozen’ differed. </p> <p>For the studies comparing ‘IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis’, the included population represented women with different indications for PGT‐A. This variety adds to the broad applicability of results to clinical practice. Whilst cleavage stage biopsy was the most widely practiced form of embryo biopsy for over a decade (<a href="./references#CD005291-bbs2-0065" title="HartonGL , De RyckeM , FiorentinoF , MoutouC , SenGuptaS , Traeger-SynodinosJ , et al, on behalf of the European Society for Human Reproduction and Embryology (ESHRE) PGD Consortium. ESHRE PGD consortium best practice guidelines for amplification-based PGD. Human Reproduction2011;26:33-40. [DOI: 10.1093/humrep/deq231] [20966462]">Harton 2011</a>), its clinical use has now decreased. </p> <p>Cumulative live birth rate is the outcome of choice for patients for multiple reasons. A frozen transfer treatment is less burdensome, and in many settings in the world cheaper than initiating a new IVF treatment. Also, the contribution of cryopreservation programmes to the general IVF treatment effectiveness has increased dramatically in the past decades (<a href="./references#CD005291-bbs2-0110" title="WongKM , MastenbroekS , ReppingS . Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertility and Sterility2014;102(1):19-26. [DOI: https://doi.org/10.1016/j.fertnstert.2014.05.027] [PMID: 24890275 ]">Wong 2014</a>; <a href="./references#CD005291-bbs2-0071" title="MaheshwariA , McLernonD , BhattacharyaS . Cumulative live birth rate: time for a consensus?Human Reproduction2015;30(12):2703-07. [DOI: 10.1093/humrep/dev263] [PMID: 26466912]">Maheshwari 2015</a>). Both the number of frozen transfers per started IVF cycle, and the results per frozen transfer have increased (<a href="./references#CD005291-bbs2-0110" title="WongKM , MastenbroekS , ReppingS . Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertility and Sterility2014;102(1):19-26. [DOI: https://doi.org/10.1016/j.fertnstert.2014.05.027] [PMID: 24890275 ]">Wong 2014</a>). Cumulative live birth rate was therefore the primary outcome in our review. However, we have also reported the live birth rate after the first embryo transfer, as this is common in the PGT‐A literature. It must be noted that this outcome favours PGT‐A by design, and should thus only be considered in the right context. It appears that embryos selected by PGT‐A have in themselves a higher implantation potential, but with PGT‐A fewer embryos will be available for transfer. For a fair comparison, for example to evaluate whether embryos were left out rightfully after PGT‐A, all embryos should be taken into account, which is reflected by the cumulative live birth rate. We have reported both outcomes, cumulative live birth rate and live birth rate after the first transfer, per woman randomised. Reporting rates after the first transfer (including only women who received a transfer) is simply incorrect when evaluating IVF effectiveness, and will favour PGT‐A by design (<a href="./references#CD005291-bbs2-0062" title="GriesingerG . Beware of the 'implantation rate'! Why the outcome parameter 'implantation rate' should be abandoned from infertility research. Human Reproduction2016;31(2):249-51. [DOI: 10.1093/humrep/dev322]">Griesinger 2016</a>). </p> <p>Only two studies reported data on cumulative live birth rate (<a href="./references#CD005291-bbs2-0005" title="MastenbroekS , TwiskM , Van Echten-ArendsJ , Sikkema-RaddatzB , KorevaarJC , VerhoeveHR , et al. In vitro fertilization with preimplantation genetic screening. New England Jounal of Medicine2007;537(1):9-17. ">Mastenbroek 2007</a>; <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a>). The <a href="./references#CD005291-bbs2-0012" title="VerpoestW , StaessenC , BossuytPM , GoossensV , AltarescuG , BonduelleM , et al. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial. Human Reproduction2018;33(9):1767-76. [PMID: 30085138]">Verpoest 2018</a> study also reported the outcome "time to pregnancy", which did not show a significant difference between study arms. Future studies should focus on the cumulative live birth rate and time to pregnancy, where a time horizon (e.g. of 12 months after randomisations) could be considered. </p> <p>According to the applicability, it is important to emphasise that the PGT‐A with the use of FISH for genetic analysis is an outdated technical procedure. More advanced genome‐wide analyses approaches are today widely applied, although we await more recent and robust data to support the evidence. </p> </section> <section id="CD005291-sec-0108"> <h3 class="title" id="CD005291-sec-0108">Quality of the evidence</h3> <p>Using the GRADE approach, we found the evidence for all outcomes comparing the addition of PGT‐A on IVF with the use of genome‐wide analyses versus the control group to be of low quality due to the limited number of studies comparing PGT‐A, inconsistency, imprecision, and the risk of publication bias. As there are four ongoing trials registered (<a href="./references#CD005291-bbs2-0027" title="NCT01946945. Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis [Comparison of Standard ART Practice vs. Trophectoderm Biopsy, Whole Chromosome Analysis by Next Generation Sequencing, and Replacement of a Single Euploid Embryo]. clinicaltrials.gov/ct2/show/NCT01946945 (first received 20 September 2013). ">NCT01946945</a>; <a href="./references#CD005291-bbs2-0029" title="NCT02032264. Nexgen [Evaluation of the Efficacy of Next Generation Sequencing in Predicting Embryonic Karyotype and Subsequent Pregnancy Outcomes in in Vitro Fertilization Cycles (IVF)]. clinicaltrials.gov/ct2/show/NCT02032264 (first received 10 January 2014). ">NCT02032264</a>; <a href="./references#CD005291-bbs2-0020" title="NCT02265614. PGS Using Microarray in IVF Patients With Repeated Implantation Failure [Preimplantation Genetic Screening (PGS) Using Microarray Technique: Method to Select the Embryo With the Greatest Chance for Successful Implantation During in Vitro Fertilization in Couples With a History of Unsuccessful IVF Attempts]. https://clinicaltrials.gov/ct2/show/NCT02265614 16-10-2014. ">NCT02265614</a>; <a href="./references#CD005291-bbs2-0030" title="NCT02353364. Blastocyst Euploidy Assessment and Conditioned embryO traNsfer (BEACON) [Prospective Randomised Control Trial of Blastocyst Euploidy Assessment and Conditioned Embryo Transfer for Infertility Patients of Advanced Maternal Age]. clinicaltrials.gov/ct2/show/NCT02353364 (first received 2 February 2015). ">NCT02353364</a>), with a study start before 2015, an estimated completion date in the past, and not published, we need to take publication bias into account. </p> <p>For the comparison addition of PGT‐A on IVF with the use of FISH for the genetic analysis versus the control group, we assessed the evidence for cumulative live birth rate as low quality due to the limited number of studies comparing PGT‐A. Evidence for the other outcomes in this comparison was of low to moderate quality. </p> </section> <section id="CD005291-sec-0109"> <h3 class="title" id="CD005291-sec-0109">Potential biases in the review process</h3> <p>Given the extensive search strategy, including the electronic database search and handsearching of relevant references, the chance of incomplete identification of studies was low. We aimed to identify all eligible studies for inclusion in this review, and contacted the authors of included studies on many occasions in an effort to include as much information as possible. The authors of most studies were forthcoming with further study information, which helped us to accrue a full picture of the study outcomes, as well as providing information needed to assess and establish risk of bias. </p> </section> <section id="CD005291-sec-0110"> <h3 class="title" id="CD005291-sec-0110">Agreements and disagreements with other studies or reviews</h3> <p>Our results are in line with the outcomes of the previous Cochrane Review, <a href="./references#CD005291-bbs2-0101" title="TwiskM , MastenbroekS , vanWelyM , HeinemanMJ , Van der VeenF , ReppingS . Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD005291. [DOI: 10.1002/14651858.CD005291.pub2]">Twisk 2006</a>, in concluding that PGT‐A performed with embryo biopsy in cleavage stage using FISH for the genetic analysis decreases live birth rates per first embryo transfer. In <a href="./references#CD005291-bbs2-0101" title="TwiskM , MastenbroekS , vanWelyM , HeinemanMJ , Van der VeenF , ReppingS . Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD005291. [DOI: 10.1002/14651858.CD005291.pub2]">Twisk 2006</a>, all trials used FISH for the genetic analysis. <a href="./references#CD005291-bbs2-0101" title="TwiskM , MastenbroekS , vanWelyM , HeinemanMJ , Van der VeenF , ReppingS . Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews2006, Issue 1. Art. No: CD005291. [DOI: 10.1002/14651858.CD005291.pub2]">Twisk 2006</a> did not evaluate the outcome of cumulative live birth rate. There is insufficient evidence as to whether PGT‐A with the use of FISH for the genetic analysis improves cumulative live birth rate. </p> <p>The European Society for Human Reproduction and Embryology stated very recently that using FISH for genetic analysis is not recommended for PGT‐A, as only a subset of chromosomes can be tested, and better genome‐wide analysing techniques exist (<a href="./references#CD005291-bbs2-0055" title="ESHRE PGT-SR/PGT-A Working Group, CoonenE , RubioC , ChristopikouD , DimitriadouE , GontarJ , et al. ESHRE PGT Consortium good practice recommendations for the detection of structural and numerical chromosomal aberrations. Progress in Human Reproduction Open2020;3:1-12. [DOI: 10.1093/hropen/hoaa017 ]">ESHRE PGT‐SR/PGT‐A Working Group 2020</a>). </p> <p>In line with the results of our review, the American Society of Reproductive Medicine stated there was insufficient evidence to recommend the use of blastocyst biopsy with aneuploidy testing, with the use of genome‐wide analyses and the use of FISH for the genetic analysis (<a href="./references#CD005291-bbs2-0038" title="Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertility and Sterility2018;109(3):429-36. [DOI: 10.1016/j.fertnstert.2018.01.002]">ASRM 2018</a>). </p> <p>Technologies have been developed in the fields of genomics and biopsy techniques. We added the comparison ‘IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses’ to the review, for which we could only include two published trials. Since the introduction of PGT‐A with these new approaches, there are no published systematic reviews with the same inclusion and exclusion criteria on the topic of PGT‐A with the use of genome‐wide analyses. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005291-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD005291-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005291-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005291-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.1 Cumulative live birth rate after the first treatment cycle, per woman randomised." data-id="CD005291-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.1 Cumulative live birth rate after the first treatment cycle, per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.2 live birth rate after the first embryo transfer per woman randomised." data-id="CD005291-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, outcome: 1.2 live birth rate after the first embryo transfer per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 IVF without PGT‐A versus IVF with PGT‐A with the use of genome‐wide analyses, outcome: 1.3 Miscarriage rate per woman randomised." data-id="CD005291-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 IVF without PGT‐A versus IVF with PGT‐A with the use of genome‐wide analyses, outcome: 1.3 Miscarriage rate per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.1 Cumulative live birth rate after the first treatment cycle, per woman randomised." data-id="CD005291-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.1 Cumulative live birth rate after the first treatment cycle, per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.2 live birth rate after the first embryo transfer per woman randomised." data-id="CD005291-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, outcome: 2.2 live birth rate after the first embryo transfer per woman randomised. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-FIG-08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 1: Cumulative live birth rate after the first treatment cycle, per woman randomised" data-id="CD005291-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 1: Cumulative live birth rate after the first treatment cycle, per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 2: Live birth rate after the first embryo transfer per woman randomised" data-id="CD005291-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 2: Live birth rate after the first embryo transfer per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 3: Miscarriage rate per woman randomised" data-id="CD005291-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 3: Miscarriage rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 4: Miscarriage rate per clinical pregnancy" data-id="CD005291-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 4: Miscarriage rate per clinical pregnancy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 5: Clinical pregnancy per woman randomised" data-id="CD005291-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 5: Clinical pregnancy per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 6: Multiple pregnancy per woman randomised" data-id="CD005291-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 6: Multiple pregnancy per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 7: Multiple pregnancy rate per live birth" data-id="CD005291-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 7: Multiple pregnancy rate per live birth </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 8: Proportion of women reaching embryo transfer per woman randomised" data-id="CD005291-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 8: Proportion of women reaching embryo transfer per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 9: Mean number of embryos transferred per transfer" data-id="CD005291-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses, Outcome 9: Mean number of embryos transferred per transfer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 1: Cumulative live birth rate after the first treatment cycle, per woman randomised" data-id="CD005291-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 1: Cumulative live birth rate after the first treatment cycle, per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 2: Live birth rate after the first embryo transfer per woman randomised" data-id="CD005291-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 2: Live birth rate after the first embryo transfer per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 3: Miscarriage rate per woman randomised" data-id="CD005291-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 3: Miscarriage rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 4: Miscarriage rate per clinical pregnancy" data-id="CD005291-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 4: Miscarriage rate per clinical pregnancy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 5: Ongoing pregnancy rate per woman randomised" data-id="CD005291-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 5: Ongoing pregnancy rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 6: Clinical pregnancy per woman randomised" data-id="CD005291-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 6: Clinical pregnancy per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 7: Multiple pregnancy rate per woman randomised" data-id="CD005291-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 7: Multiple pregnancy rate per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 8: Multiple pregnancy rate per live birth" data-id="CD005291-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 8: Multiple pregnancy rate per live birth </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 9: Proportion of women reaching embryo transfer per woman randomised" data-id="CD005291-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 9: Proportion of women reaching embryo transfer per woman randomised </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005291-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/urn:x-wiley:14651858:media:CD005291:CD005291-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 10: Mean number of embryos transferred per transfer" data-id="CD005291-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_t/tCD005291-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis, Outcome 10: Mean number of embryos transferred per transfer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/media/CDSR/CD005291/image_n/nCD005291-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005291-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Preimplantation genetic testing for aneuploidies with the use genome‐wide analyses in in vitro fertilisation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Preimplantation genetic testing for aneuploidies with the use genome‐wide analyses in in vitro fertilisation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> couples with an in vitro fertilisation indication<br/><b>Settings:</b> fertility clinics<br/><b>Intervention:</b> PGT‐A with the use of genome‐wide analyses </p> <p><b>Comparison:</b> no PGT‐A </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes per woman</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Embryo stage of biopsy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>PGT‐A with the use of genome‐wide analyses</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cumulative live birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>236 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>245 per 1000<br/>(169 to 338) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.05<br/>(0.66 to 1.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Live birth rate after the first embryo transfer</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>199 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>215 per 1000</p> <p>(144 to 308)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.10<br/>(0.68 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Blastocyst stage biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>435 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>417 per 1000</p> <p>(347 to 494)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.93<br/>(0.69 to 1.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>661<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>141 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>69 per 1000<br/>(36 to 127) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.45<br/>(0.23 to 0.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Blastocyst stage biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>82 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73 per 1000</p> <p>(44 to 121)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.89<br/>(0.52 to 1.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>661<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported on ongoing pregnancy.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Polar body biopsy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>366 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>308 per 1000<br/>(224 to 402) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.77<br/>(0.50 to 1.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>396<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>PGT‐A:</b> preimplantation genetic testing for aneuploidies; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision: results based on one study, small number of events; CI crosses the line of no effect.<br/><sup>b</sup>Downgraded two levels for imprecision: results based on one study, small number of events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Preimplantation genetic testing for aneuploidies with the use genome‐wide analyses in in vitro fertilisation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005291-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Preimplantation genetic testing for aneuploidies with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis in in vitro fertilisation</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p>Preimplantation genetic testing for aneuploidies with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis in in vitro fertilisation </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> couples with an in vitro fertilisation indication<br/><b>Settings:</b> fertility clinics<br/><b>Intervention:</b> PGT‐A with the use of FISH for the genetic analysis </p> <p><b>Comparison:</b> no PGT‐A </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes per woman</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect <br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p>PGT‐A with the use of <b>FISH</b> for the genetic analysis </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cumulative live birth</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>287 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>192 per 1000<br/>(124 to 289) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.59<br/>(0.35 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Live birth rate after the first embryo transfer</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>307 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>215 per 1000<br/>(160 to 287) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.62<br/>(0.43 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000<br/>(81 to 143) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.03<br/>(0.75 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1680<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ongoing pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>274 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>204 per 1000<br/>(161 to 253) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.68<br/>(0.51 to 0.90) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1121<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Clinical pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>333 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>219 per 1000<br/>(174 to 267) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.56<br/>(0.42 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1131<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>PGT‐A:</b> preimplantation genetic testing for aneuploidies; <b>RCT:</b> randomised controlled trial </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision: results based on one study, small number of events.<br/><sup>b</sup>Downgraded one level for inconsistency: I² &gt; 50% in results across studies.<br/><sup>c</sup>Downgraded one level for imprecision: the CI for most studies crosses the line of no effect, or small number of events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Preimplantation genetic testing for aneuploidies with the use of fluorescence in situ hybridisation (FISH) for the genetic analysis in in vitro fertilisation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/full#CD005291-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005291-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Cumulative live birth rate after the first treatment cycle, per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Live birth rate after the first embryo transfer per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.68, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.69, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Miscarriage rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.23, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.52, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Miscarriage rate per clinical pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.22, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Clinical pregnancy per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Multiple pregnancy per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.20, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.20, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Multiple pregnancy rate per live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.16, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.16, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Proportion of women reaching embryo transfer per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>396</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.18, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.16, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Mean number of embryos transferred per transfer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Polar body biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐0.49, ‐0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IVF with PGT‐A versus IVF without PGT‐A with the use of genome‐wide analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005291-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Cumulative live birth rate after the first treatment cycle, per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Live birth rate after the first embryo transfer per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.43, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1579</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.44, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.18, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Miscarriage rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.75, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1579</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.72, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.50 [0.51, 39.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Miscarriage rate per clinical pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>288</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [1.10, 2.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [1.17, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.08, 3.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Ongoing pregnancy rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.51, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.51, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Clinical pregnancy per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.45, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1030</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.46, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.21, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Multiple pregnancy rate per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.37, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.37, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Multiple pregnancy rate per live birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.51, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.51, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Proportion of women reaching embryo transfer per woman randomised <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.40, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.40, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 Blastocyst stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.02, 9.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Mean number of embryos transferred per transfer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.30, ‐0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 Cleavage stage biopsy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1433</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.30, ‐0.16]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">IVF with PGT‐A versus IVF without PGT‐A with the use of FISH for the genetic analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005291.pub3/references#CD005291-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005291.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005291-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005291-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005291-note-0009">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD005291-note-0012">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD005291-note-0008">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD005291-note-0010">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005291\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005291\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005291\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005291\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005291\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jxlIh5Me&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005291.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005291.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005291.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005291.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005291.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729732800"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005291.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729732804"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005291.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ee4173ff69377',t:'MTc0MDcyOTczMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 